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It is much more important to know what sort of a patient has a disease than what sort of a 
disease a patient has. 
William Osler (1904), quoting Hippocrates 
 
“…my final words to current NPs…is to take risks, chart new directions, study the 
results, learn from your mistakes, and enjoy change…Meliora, means ‘onward and 
upward’ challenging each of us to climb to his or her ‘farthest star’.” 
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No research project is really complete without its larger context. For me that 
larger context is my passion in the arena of patient care. I want to introduce you to patient 
of mine named Jack. 
 Jack was a 38-year-old gentleman who presented with his wife to my genital pain 
clinic. He had a history of right-sided testicular pain for over two and half years. He was 
initially evaluated by his primary care provider and referred to urologist. At the urologist 
he was prescribed multiple short courses of antibiotics, occasional narcotics, imaging 
studies, and more antibiotics and narcotics. None of these modalities help to address his 
pain, and after year he gave up; he and his wife decided to manage his pain at home as 
best they could. Over a year later, he re-presented with the same complaint to his primary 
care provider and this time was referred to my Chronic Male Genital Pain clinic. I asked 
about things that made his pain better or worse and the overall quality of his pain and 
how much interfered with his life. He reported that when his testicular pain was worse he 
also had hip pain and pain that radiated down his thigh to his knee. It became very clear 
that his pain was directly related to his work, which involved much heavy lifting, 
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standing, and walking. It was at times where his work was most physical that his pain 
was worst. He also had a bit of a paunch that probably contributed to his back strain. I 
discussed with Jack and his wife that my plan was a trial of anti-inflammatory 
medications, a non-sedating muscle relaxer, and physical therapy for his back. Jack and 
his wife left this clinic visit feeling their concerns had been heard, and in full agreement 
with the plan of care that we developed. 
It has long been my goal to solve the puzzle of chronic genital pain in men, and to 
provide evidence for other providers to be able to do the same. This dissertation research 
is my first step towards that goal. 
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Chronic pain is a public health issue in the United States. Men with chronic 
unexplained orchialgia (CUO) are an understudied population, with significant 
knowledge gaps regarding to demographics, etiology, and reliable treatment. This 
dissertation  begins to address these gaps in knowledge, within a framework that presents 
an organized conceptual view of this chronic pain condition. The dissertation  research 
and interpretation of its results interpretation are guided by the Biopsychosocial Model.  
This dissertation explored the feasibility of a clinic dedicated to the evaluation 
and management of adult men with chronic genital pain, but focused on screening for 
men with CUO. A total of 228 men were screened over 12.5 months; 124 reported 
chronic genital pain. 104 men had chronic testicular pain that had an identifiable cause; 
varicocele was the most common diagnosis (n = 55). 20 men had true CUO. This 
dedicated chronic male genital pain clinic established treatable causes for 84% of men 
referred for alleged CUO. This represents cost saving for men and healthcare by avoiding 
unnecessary surgical procedures. 
The second aspect of this dissertation was a cross-sectional sample case series. 
All 20 men with CUO were consented; 70% (n = 14) of the men returned a survey packet 
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consisting of 16 standardized psychometric instruments evaluating the multidimensional 
nature of chronic pain. Instruments were evaluated with a sample of n = 12 in most cases. 
Demographic characteristics in the sample diverged from what has been previously 
reported about education and income. The median pain score was 4.00 out of 10 in the 
sample, with a median pain duration of 38.69 months. Men in the sample did not report 
urinary symptoms, depression/anxiety, or catastrophizing; instruments did not suggest a 
specific pain mechanism. Results showed evidence for self-reported dyscognition, fatigue 
and little belief in their own ability to decrease their pain. None reported a history of 
sexual trauma. Men reported less interference from chronic pain comorbidities in this 
sample than anticipated, SF-12 results conflicted with the other survey instruments, 
showing more impairment. This resaerch is the first to use standardized instruments to 





Introduction To The Problem Of Chronic Unexplained Orchialgia 
 
Introduction 
 Over 116 million Americans suffer from chronic pain at a cost of over 635 billion 
dollars yearly in direct medical costs and decreased productivity (Institute of Medicine, 
2011). Chronic pain is a current priority of the national healthcare agenda, consistent with 
the Healthy People 2020 (Centers for Disease Control and Prevention [CDC], 2014) to 
reduce the number of patients suffering from untreated pain. The Patient Protection and 
Affordable Care Act (Section 4305, 2010) mandated that the Secretary of Health and 
Human Services work with the Institute of Medicine to raise awareness of chronic pain as 
a public health issue. 
Investigation of chronic pain is a goal of the National Pain Strategy, one that 
seeks to better quantify the prevalence of pain in the United States and especially in 
specific population groups (Interagency Pain Research Coordinating Committee 
[IPRCC], 2015). The National Pain Strategy embraces work designed to create baseline 
knowledge in understudied populations to advance and assess physical, psychological 
and social treatments. Because of the dynamic interaction among the biologic and 
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psychosocial factors that modulate an individual's description of pain and his/her 
potential disability, both the IOM and the National Pain Strategy Chronic acknowledge 
that chronic pain cannot be broken down into discrete psychosocial and physical 
components. The National Pain Strategy seeks to formulate strategies to address 
economic burdens that accompany chronic pain, especially those that prevent absence 
from work and dependence on medications.  
 This dissertation research begins to address the gap in knowledge about a specific 
subpopulation of understudied and underdescribed men: men with chronic unexplained 
orchialgia. 
Background of the Problem 
The national focus on chronic pain forms the backdrop that inspired this 
dissertation research to work toward clinical characterization of men with chronic 
unexplained orchialgia (CUO). Men living with CUO face many barriers to care, 
including finding a provider able to accurately evaluate their pain complaint (Quallich, 
2016). Chronic unexplained orchialgia is a genital pain condition unique to men and one 
that lacks an evidence-based treatment algorithm. These factors contribute to men with 
CUO seeking evaluation and treatment from multiple providers, consistent with the 
behaviors of other populations with chronic pain (Hong, Corcoan, & Adams, 2009). CUO 
has an unknown incidence with no precedent for evaluating it as a multifactorial 
condition. Much remains to be learned about any underlying syndrome etiology for CUO; 
the natural history of CUO (i.e., how this syndrome develops and changes over time); the 
influence of the patient’s genetics; and biological, environmental, and lifestyle risk 
factors to CUO development and progression. Social and cultural factors influence 
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chronic pain severity and subsequent disability (Gatchel & Mayer, 2008; IOM, 2011). 
Physical findings alone may not provide a complete, satisfactory or holistic description 
for pain nor uncover potential etiologies. The Institute of Medicine acknowledges the 
need for a subjective conceptualization of pain that characterizes its complex evolution of 
biological, behavioral, environmental and societal factors in individuals (IOM, 2011).  
Statement of the Problem 
Men with CUO are evaluated in primary care, urology, neurology, physical 
therapy and pain clinics (Ciftci, Savas, Yeni, Verit, & Topal, 2010), and although they 
may represent a small number of men, the impact of their CUO on quality of life, social, 
sexual and economic circumstances may be substantial. A recent literature review 
(Quallich & Arslanian-Engoren, 2013) reveals sparse research on predictive factors that 
contribute to CUO or resulting rates of disability. There is also a lack of knowledge 
regarding reliable, non-surgical treatments (Quallich & Arslanian-Engoren, 2013). This 
meager literature base represents a distinct gap in the knowledge about this subpopulation 
of men, and contributes to a gender disparity relative to knowledge of a chronic genital 
pain condition in men. Undertreatment of chronic pain creates a risk for decreased quality 
of life, and other comorbidities such as psychsocial decline and decreased functional 
status (Fine, 2011). In this context, it is imperative to understand and treat men with CUO 
more effectively; this dissertation research works toward closing this knowledge gap 
through these initial steps toward clinical characterization. 
 This dissertation research takes the first steps to better understand CUO within a 
biopsychosocial model and is the first study of its kind to evaluate men with CUO 
standardized psychometric instruments, an approach which has proven valuable in other 
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chronic pain conditions. Results from this study will promote understanding of a more 
comprehensive approach to pain assessment and treatment for men with CUO, and may 
offer insight into improving assessment of psychological traits or states that influence 
expectations, beliefs, and the impact of chronic pain on their lives.  
Hypotheses 
This dissertation research was designed with three distinct, but progressively 
interrelated hypotheses. These hypotheses are designed to generate data that begins to 
address the gaps in knowledge and test feasibility of a method for establishing a source 
population of CUO for future study:  
Aim 1. To test the feasibility of a method for identifying a source population of 
CUO for future study.  
Hypothesis: Establishing a specialized clinic for men with chronic genital pain 
will provide a source population pool of ~30% with true chronic unexplained 
orchialgia at time of clinic evaluation. 
Aim 2. To determine the feasibility of asking men with CUO to complete a 
lengthy survey battery of tools (some with sensitive information) to in a group of 
men with CUO. 
Hypothesis: >80% of men diagnosed with true chronic unexplained orchialgia at 
time of clinic evaluation will fill out every survey instrument. 
Aim 3. Obtain pilot data to inform a future study designed to fully characterize 
the biopsychosocial aspects of CUO. 
Hypothesis: Men with chronic unexplained orchialgia will demonstrate comorbid 





The dissertation research was divided into two parts. The first part was a 
feasibility study consisting of a convenience sample of men with male genital pain seen 
in an adult urology specialty clinic. These details and results are discussed in Chapter 3. 
The second part of the research was a pilot of a cross-sectional design using a selection of 
psychometric instruments to gather data exploring the multidimensional chronic pain 
experience of men meeting inclusion criteria; these details and results are discussed in 
Chapter 4. The long-term goal of exploring this subpopulation with a pilot study is to 
work toward the exploration of a full clinical characterization for men with CUO. Figure 
1 offers a visual representation of the dissertation research. 
Theoretical Approach 
The theoretical model for this dissertation research drew directly from the IOM 
(2011) recommendations, thereby aligning it with the national chronic pain research 
agenda. The IOM (2011) recommended the Biopsychosocial Model (BPSM) (Engle, 
1977) because this model best represents the complexity of encounters in clinical 
populations with chronic pain. The IOM report further recommends that research 
evaluating the characteristics of chronic pain place antecedents and consequences within 
the framework of the Biopsychosocial Model, acknowledging that chronic pain is a 
dynamic entity and can interfere with multiple aspects of life. 
The Biopsychosocial Model 
In 1977, psychiatrist George Engel published his initial proposal for the 
Biopsychosocial Model (Engel, 1977). This model was borne from the recognition of a 
need to revise both the manner in which physicians thought about patients and 
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approached patients. Engel discussed the need for medicine and psychiatry to 
acknowledge the overlap in somatic parameters and psychosocial manifestations of 
disease.  He expressed frustration with what he described as lack of interest in the person. 
He saw that the pure biomedical approach, where illness was defined as physiological 
deviations from some normal, was failing as it tried to maintain its classic mind-body 
dualism, especially in the distinction between medicine and psychiatry. Engel’s model 
proposed a new dualism, one that advocated approaching an individual as a unique, 
biologic organism and as an individual within his larger social environment. The BPSM 
aimed to reverse the way in which medicine relegated “the psychosocial to other health 
professionals, such as nurses, social workers or psychologists” (Engel, 1982, p. 804). It 
seeks to integrate the way in which medical knowledge regarding illness and disease 
could be applied more individually within each clinical interaction.  
The BPSM has its origins in general systems theory (Von Bertalanffy, 1968) and 
its approach to the interrelatedness of systems and processes; this allows inclusion of 
social and psychosocial conditions within a larger process for medical care. Within the 
BPSM, the individual is viewed as part of a hierarchy that recognizes distinct components 
as parts of a larger system (e.g. community) (Engel, 1982). As such, the BPSM 
emphasizes that a particular symptom or complaint exists within a larger context of the 
person’s history, experiences and sensations. The specific presentation of an individual at 
any given time is subject to a variety of smaller influences (e.g., social, sexual and 
cultural norms) within the hierarchy that might not be initially apparent (Borrell-Carrio, 
Suchman & Epstein, 2004)  
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The BPSM proposes that the interaction of biologic/physiologic, psychological, 
social and behavioral components creates “patienthood” (Engel, 1977). It asserts that 
without a way to correlate biochemical abnormalities with the behavioral and 
psychological manifestations seen clinically, the temptation would be to circumvent 
symptoms and focus only “on technical procedures and laboratory measurements” 
(Engel, 1977, p. 132).  “The biomedical model ignores both the rigor required to achieve 
reliability in the interview process and the necessity to analyze the meaning of the 
patient's report in psychological, social, and cultural as well as in anatomical, 
physiological, or biochemical terms” (Engel, 1977, p. 132). The social context, living 
environment and “the complementary system (the healthcare system) devised by society 
to deal with the disruptive effects of illness” (Engel, 1977, p. 132) must all be 
acknowledged when defining illness or health.  
BPSM and Illness 
Disease in the BPSM is a concept defined as a biologic condition that is 
disruptive, in any anatomical, pathological, physiological or psychological domains 
(Gatchel et al., 2007; Gatchel, McGeary & Lippe, 2014). The concept of illness is defined 
as subjective sense of unwell, reflecting both on person and his community (Epstein et 
al., 2003) and symptoms may not represent the full extent of a disease. This perspective 
allows for causes of illness outside the individual and presents an opportunity for both the 
individual and the provider to acknowledge causes of illness outside the traditional 
constraints of the biomedical model. This also implies that situations can sustain illness, 
through secondary benefits (e.g. disability, increased spousal attention) or monetary gain 
(e.g. disability payments). 
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The BPSM acknowledges that individuals filter and process their experience, a 
perspective particularly congruent with the process of appraisal in chronic pain states. 
Individuals “edit” their report of their symptoms while presenting them, either to 
providers or in a social environment, which influences care seeking, compliance and the 
nature of the relationship with the provider. The result is a narrative that places their 
(pain) experience in a particular social context, replete with expectations about both the 
illness and treatment. The BPSM embraces this narrative and its representation of a larger 
(social) context, thereby offering insight into potential treatment approaches or avenues 
for success. The experience of pain is subjective and unique; the BPSM describes the 
integration of evidence-based approaches to care with a dynamic understanding of an 
individual. 
The biopsychosocial approach proposes that all patients can be healed, although 
not necessarily cured (Epstein et al., 2003) and this may be partially through 
acknowledgment of their narrative and affirmation of their subjective experience by those 
hearing the description of their experience. This shifts the focus from a one-way 
physician-to-patient arrangement to a bidirectional relationship-centered model for care, 
incorporating social constructivism into this biopsychosocial approach to patients by 
acknowledging that an individual’s (pain) reality and experience are heavily influenced 
by social contexts (Williams, Frankel, Campbell, & Deci, 2003). The BPSM further 
emphasizes self-identity evaluating whether or not the patient views himself as sick or 
disabled as part of his initial assessment. This also requires that a provider consider the 
potential benefits of an individual's decision to accept his “patienthood” and his 
subsequent role in his own health care (Engel, 1977). Illness becomes a subjective 
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experience or self-attribution that disease is present (Gatchel, et al., 2007; Gatchel & 
Mayer, 2008), and encompasses how the individual and his support system respond to 
illness or disability (Gatchel, 2004).  
Engel’s model (Figure 2) emphasizes the unique, subjective experience of the 
individual and allows researchers to identify the influence of both biological and 
psychosocial conditions within a dynamic framework for study (Gatchel, 2004). In 1997, 
Engel commented that the BPSM “provides a conceptual framework conducive to 
accommodating the human domain scientifically” (p. 527). The BPSM acknowledges 
differences in perspective and interpretation, in that some people view sensations as part 
of life while others identify various sensations as indicators for disease or illness.  
The BPSM values an interdisciplinary approach, suggesting that failure to 
collaborate with other disciplines will sustain past failures that did not treat the man as a 
sum of his individual experiences. This approach will repeat the failures Engel first 
recognized in the biomedical perspective. The BPSM model is similar in nature to grand 
theories in nursing, in that it provides a framework for conceptualization of clinical 
problems and it can be easily adapted to a variety of research interests. 
Alternative Model 
The nursing Theory of Unpleasant Symptoms (TOUS) (Lenz, Suppe, Gift, Pugh, 
& Milligan, 1995) was considered as a model to ground this dissertation research. The 
BPSM and TOUS both acknowledge the influence of multiple factors on an individual at 
any point in time. The BPSM and TOUS aim to treat an individual’s experience in a 
complete and holistic manner. Neither the TOUS or the BPSM confine themselves to the 
evaluation of a single variable, symptom or condition, resulting in the potential for wide 
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application across a variety of disciplines. To date, the TOUS has been rarely used  
outside of nursing. This lack of wide adoption of the TOUS made selection of the 
Biopsychosocial Model for this dissertation research necessary to align this dissertation 
research with the national recommendations for the interdisciplinary approach to chronic 
pain.  
Summary 
Men with CUO may benefit from a comprehensive approach to pain assessment. 
In particular, the scores on standardized psychometric instruments may suggest a clinical 
presentation that is similar to other better-studied chronic pain, providing insight into 
more effective treatments.  This new insight will promote more efficient use of healthcare 
resources, and prevent unnecessary trials of medical or surgical management. These goals 
must be closely paralleled with a reduction in bias towards this particular population, 
both in terms of sensitivity to health seeking behaviors in men (Hooper & Quallich, 
2016) and the social and cultural stereotypes ascribed to masculinity when dealing with 
pain. Results from this dissertation project will also serve to close the gap in knowledge 
regarding this particular subpopulation of pain patients, and begin to decrease the 
disparity in what is known about chronic genital pain conditions in men. The results of 
this project can be immediately translated to advances in the clinical management of men 
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Chronic Unexplained Orchialgia within the Context of Chronic Pain in General 
 
Chronic pain is a current priority of the national healthcare agenda. 
Approximately 126 million American adults suffer from some form of chronic pain 
(Kennedy, Roll, Schraudner, Murphy, & McPherson, 2014). Over $635 billion is spent 
each year on medical care and lost productivity (IOM, 2011). Chronic unexplained 
orchialgia (CUO) is one of many specific chronic pain conditions. As with chronic pain 
in general, CUO is understudied and is poorly understood. This chapter provides a 
background for CUO and places what is known about CUO within the context of the 
larger body of literature on chronic testicular pain and chronic pain in general.  
Integrative Review of the Chronic Testicular Pain Literature 
Chronic pain is a complex and difficult clinical symptom for clinicians to 
understand because of its personal nature and an individual’s subjective perception and 
past experiences (Gatchel, Peng, Peters, Fuchs, & Turk, 2007; Tait & Chibnall, 2014; 
Turk & Melzack, 2011). A recently published integrative literature review spanning 
January 1970-September 30, 2012, demonstrated the sparse body of research knowledge 
available discussing the clinical presentation of men with CUO (Quallich & 
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& Arslanian Engoren, 2013;  Appendix A). Results of the literature review support the 
need for an investigation into men with CUO that includes parameters such as “its impact 
on daily activities, any disability related to pain, an account of utilization of services, and 
the costs of pain and pain care” (p. 402, Quallich & Arslanian-Engoren, 2013). The 
scarcity of this information in papers published prior to 2013 highlights the lack of 
information on which to base our understanding of men with CUO.  
Since publication of this integrative review, only six publications met the 
inclusion criteria of the original integrative literature review (Cassidy, 2015; Cui & 
Terlecki, 2016; Khambati, Lau, Gordon, & Jarvi, 2014; Marconi, et al., 2015; Najari, 
Robinson, Paget, & Paduch, 2014; Parekattil, Gudeloglu, Brahmbhatt, Priola, Vieweg, & 
Allan, 2013). Of these six papers, four are research papers (Table 1) and two are case 
review papers (Table 2) investigating treatment and management for adult men with 
CUO. Consistent with observations in the Quallich and Arslanian-Engoren (2013) review 
of the literature, these new papers include sparse information about demographics, pain 
characteristics or site of pain. These recent published papers continue the focus on 
surgical treatment (such as spermatic cord denervation) for the unexplained orchialgia, 
adding little the understanding of the CUO population.  
Chronic Pain  
The Interagency Pain Research Coordinating Committee (IPRCC) was developed 
in 2011 by the Department of Health and Human Services to organize pain research and 
activities. The task of the IPRCC is to identify critical gaps in basic and clinical research 
on symptoms and causes of pain and support population-based research regarding the 
incidence and prevalence of chronic pain. The IPRCC encourages population-based 
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research to help reduce pain and remediate treatment disparities among subgroups, based 
on dimensions, such as gender or socioeconomic status. In 2011, after its creation, the 
IRPCC adopted the Institute of Medicine’s 2011 report and its recommendations, which 
proposed avenues for addressing chronic pain as a public health issue. 
This Institute of Medicine (IOM) 2011 document titled “Relieving Pain in 
America” includes specific recommendations a) for the assessment of chronic pain, b) for 
pain evaluation in previously understudied populations, and for the education of 
providers at all levels. The IOM report further recommends that future research 
evaluating antecedents and consequences of chronic pain place these characteristics 
within the framework of the Biopsychosocial Model (Engel, 1977) (ref), emphasizing the 
subjective experience of the individual, and allowing researchers to place the influence of 
biological and psychosocial conditions within a framework for study. The report 
concludes that the cost of chronic pain is so significant, in terms of healthcare dollars and 
social consequences, that additional study is imperative. The IPRCC recently reinforced 
the IOM’s recommendations when issuing the National Pain Strategy to work toward an 
evidence-based, culturally sensitive prevention and care algorithm (IPRCC, 2015).  
Comorbid and Allied Pain Conditions 
From a utilitarian perspective, the most basic function of acute pain is to 
command one's attention to possible injury that might threaten survival. In the absence of 
acute tissue damage or injury, such as with chronic pain, prolonged pain is largely 
maladaptive. Chronic pain impacts many domains, not solely psychological or physical 
ones (IOM, 2011; Jensen & Turk, 2014; Molton & Terrill, 2014). Full description of the 
illness burden with chronic pain is complex, and must acknowledge age-related 
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differences. Fine (2011) reviewed numerous studies that reported the negative impact that 
pain has on multiple domains, including 
• Quality of life; 
• Functional capacity/limited activity; 
• Fatigue; 
• Sleep disturbance/sleep deprivation; 
• Mood (depression/anxiety/anger); 
• Dyscognition (memory/attention); 
• Coping mechanisms; 
• Gender-specific issues, such as sexual function. 
This review (Fine, 2011) demonstrated a lack of association between chronic pain and 
sexual function, although the individual comorbidities listed can each impact sexual 
function.  
Since Fine’s 2011 review, the relationship of chronic pain with mood has been 
investigated. Pain itself provokes an emotional response; it is this unique reaction that 
sets the stage for treatment successes and failures, as well as potential disability (Watson 
& Kendall, 2013). Pain is an independent risk factor for depression; depression, is both a 
normal reaction to pain and decreased activity, but can also become pathologic in chronic 
pain states (Watson & Kendall, 2013). A recent review of modulation of pain by 
cognitive and emotional states shows positive or negative moods and expectations can 
influence treatment outcomes and decrease or increase reports of pain (Busnell, Ceko & 
Low, 2013). Gatchel et al. (2007) performed an extensive review of experimental models 
of pain, and reviewed the role of emotions from a “sensory-discriminative, cognitive-
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evaluative, and motivational” (p. 598) perspective. These authors note multiple studies 
linking emotional states to chronic pain, suggesting that pain and emotions interact in a 
variety of ways to promote and sustain its comorbid symptoms. For example, anxiety has 
been implicated in increased affective pain responses and maladaptive pain behaviors 
because it represents uncertainty about the future and uncertainty about the meaning of 
the pain (Gatchel et al., 2007). Lumley et al. (2011) reviewed the literature on pain and 
emotion from 2000-2010. They reported that pain-related anxiety can result in avoidance 
of activities that promote recovery and may have a role in amplification of somatosensory 
input. Psychological and social beliefs and behaviors can create and perpetuate 
maladaptive coping, such as childhood traumatic events having a role in some pain 
conditions (Lumley et al., 2011). Two other recent reviews (Jensen & Turk, 2014; 
Molton & Terrill, 2014) offer evidence that pain behaviors alone can sustain pain, and 
create disability that is not a function of the pain itself, such as a lack of movement 
leading to muscle weakness.  
Gender Gap Regarding a Chronic Genital Pain Condition 
In the first section of their extensive systematic literature review, Racine et al. 
(2012a) reported 10 years of published data demonstrated that experimental pain testing 
failed to establish a consistent pattern of differences between men and women. These 
authors concluded that published study results (n = 122) were heavily influenced by both 
the outcome measures (e.g. time exposed to painful stimulus, site of body tested) chosen 
by researchers and the pain modalities tested (e.g. pressure pain, ischemic pain, electrical 
pain). This has unclear implications clinically, as these results were based on controlled 
experimental conditions. This same group of authors also reviewed published studies     
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(n = 128) examining regarding possible biopsychosocial factors in pain sensitivity 
between men and women (Racine et al., 2012b). The review reported that anxiety was a 
stronger predictor of pain in men, and may have an increased effect on pain perception in 
males. Racine et al. (2012b) also stated that distraction may be an efficient coping style 
for men faced with pain. Gender expectations seem to have a role in pain perceptions in 
experimental settings, but again this is an unclear relationship to clinical presentation and 
symptom report. Racine et al. (2012b) concluded that current data is insufficient to 
establish a true influence from biopsychosocial factors or to explain differences in pain 
perception between men and women. Gender differences in pain intensity and pain 
perception, as this manifests clinically, remain poorly described and poorly understood.  
This is despite clear gender differences in prevalence for some types of chronic pain, 
such as fibromyalgia, leading to speculation that there are gender differences in pain 
perception although to date evidence for this is inconclusive.   
El-Shormilisy, Strong, and Meredith (2015) performed a systematic review with 
strict inclusion criteria (adult patients, pain >3 months, measure coping/pain management 
strategies, measure function) for reporting gender-specific outcomes when evaluating 
adults with chronic nonmalignant pain. These authors reported that in the seven papers 
that met inclusion criteria, results demonstrated that men catastrophize more when in 
pain, and manifested increased anxiety, leading to increased interference from pain 
during daily functions (return to work or as measured on a pain interference scale). They 
concluded that gender-specific coping styles influenced functional status in men and 
women with nonmalignant chronic pain and confirmed the complex association of 
chronic pain with depression and anxiety (El-Shormilisy, Strong & Meredith, 2015). 
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Keogh (2015), in recent selective review that examined general themes in 
published men’s health literature, reported that men have a lower use of pain services and 
lower use of analgesics than women. Keogh (2015) suggests one’s understanding of men 
with chronic pain can be strengthened by incorporating a men's health view, one that 
incorporates acknowledgement of current psychosocial stereotypes about men and pain. 
Furthermore, men may be using avoidance by seeking multiple evaluations when they 
experience chronic pain, as they continue to pursue an explanation and diagnosis that is 
consistent with their masculine self-schema (minimizing symptoms to the point of 
insignificance, as interest in health or their bodies can be interpreted as “feminizing”) 
rather than accepting the diagnosis of “pain” (Wenger, 2011; Hooper & Quallich, 2016). 
Vulvodynia is a chronic genital pain condition in women and ongoing research 
seeks to evaluate the underlying pain mechanisms while combining specific physiologic 
and psychological interventions (Cox & Neville, 2012; Zhang et al., 2011). Standard 
evaluation of women with a chronic genital pain condition, such as vulvodynia, follows a 
process that includes questioning the woman about the personal meaning and attributes of 
her pain and its meaning in the context of her sexual function (Bergeron, 2011; Fall et al., 
2010; Haefner et al., 2005; Johansen & Weidner, 2002; Reed et al., 2014).  This 
represented a paradigm shift toward understanding this condition as multifactorial. This 
shift recognized the subjective nature of pain and the interplay of biological 
psychological and social factors that contribute to and sustain an illness experience 
(Bergeron, 2011) such as the relationship of the perceptions of their femininity and a 
desire for validation of their pain.  
The Intersection of Chronic Pain and Sexuality 
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Chronic pain affects an individual’s well-being and quality of life (Gatchel et al, 
2014; Jensen & Turk, 2014) and likely influences sexuality. Certain types of chronic 
pain, particularly chronic pelvic or genital pain, might also have direct effects on 
sexuality, and may reflect a specific aspect of the contribution of chronic pain to 
“disordered social relations” (Jensen & Turk, 2014, p.108). One’s conceptualization of  
sexuality is a direct influence of factors such as class, gender, and education, 
demonstrating the inextricable relationship between biology and the cultural reality of 
sexual behavior (Gagnon, 1975; Quallich, 2014).  
Much of the groundwork examining the relationship between chronic pain and 
sexuality is reported with chronic back pain patients (Maruta & Osborne, 1978; Osborne 
& Maruta, 1980; Sjogren & Fugl-Meyer, 1981; Vander Kolk, Chubon & Vander Kolk , 
1992; Monga, Tan, Osterman, Monga, & Grabois, 1998). A retrospective study by 
Vander Kolk et al., (1992) reported that 72% of their cohort of male and female patients 
with back injuries (n = 100) reported some degree of sexual dysfunction, determined by a 
decrease in the frequency of sexual activity, with a mean reduction of 71.82%. Only a 
small relationship was reported between pain level and reduction in frequency of 
intercourse, suggesting that other unmeasured variables impact sexual activity. Others 
have reported that subjects describe decreased sexual satisfaction at the initial onset of 
their pain (Sjogren & Fugl-Meyer, 1981).  
In a predominantly male veteran sample, Monga et al. (1998) found men (n = 62) 
and women (n = 8) with chronic paint in a variety of sites (e.g. back, legs, shoulders, 
genitals) experienced difficulties with sexual arousal, sexual behavior, climax, and sexual 
relationships, but not sexual fantasy. These authors reported that patients with pain may 
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be too distracted by their chronic pain to reach a sufficiently high level of sexual arousal, 
and that greater sexual dysfunction is associated with less successful coping mechanisms 
(e.g. catastrophizing, perceptions of decreased control, fear of pain).  In this convenience 
sample, Monga et al. (1998) showed that patients who had positive control appraisals for 
both pain and life domains had higher scores on the sexual functioning scales, while 
patients who were employed had overall better sexual function and libido than those 
receiving disability payments.  
Ambler, de C. Williams, Hill, Gunary, and Cratchley (2001) reported that in their 
sample of men and women (n = 237) that pain had a negative impact on sexual function 
for most patients, independent of mood. Their sample had a low incidence of depression 
(measured on the Hospital Anxiety and Depression Scale) despite pain with sexual 
position and sexual performance concerns.  Kwan, Roberts and Swalm (2005) suggested 
chronic pain impacts sexual activity, but this does not imply a lack of satisfaction with 
sexual activity. Kwan, Roberts and Swalm (2005) incorporated a mixed methods 
approach (prospective survey with retrospective chart review) to survey 151 men and 
women with a variety of nonmalignant chronic pain conditions. Their results offered 
evidence that men and women with chronic pain were highly adaptive, altering their 
approach to sexual activity based on physical limitations, and that satisfying sexual 
activity depended more on personal relationships and social support than successful 
resolution of all pain. These authors reported that as study participants’ health 
circumstances changed, their perspective on sexual activity and intimacy also changed, 
with sexual activity becoming less important overall to quality of life than comorbid 
domains such as sleep and activities of daily living.   
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In a small series (n = 3) Arabkheradmand et al., (2008) reported that chronic pain 
and altered erectile dysfunction often coexisted, but that erectile difficulties were not 
commonly treated in the context of chronic pain. Men were age 25, 65, and 47; no 
mention was made of ethnicity. All three men suffered a traumatic injury that resulted in 
chronic pain and sexual function complaints. Results demonstrated that treating erectile 
difficulties improved overall pain scores and alleviated psychological symptoms. 
Ruehlman, Karoly and Taylor (2008) reported that in a national US sample of 
2071 men and women aged 25 to 80 with chronic pain, 37% reported no interference with 
sexual functioning. In the men belief in a cure was a predictor of increased interference 
with sexual functioning and may be related to treatment-seeking. Regression analysis of 
the results revealed that catastrophizing was a predictor of pain interference (b = .234) on 
sexual function for both men and women. Their findings are consistent with the scant 
body of previous research demonstrating men who seek treatment for their pain report 
higher levels of disability across domains, including sexual function. This study did not 
clarify whether it is alterations in sexual function or pain itself that drives men to seek 
treatment, and conclude that “the link between gender, pain’s perceived interference with 
sexual activity, and treatment seeking merits further empirical scrutiny” (p. 134). 
Sexuality and Chronic Unexplained Orchialgia  
Only two papers to date (Ciftci et al., 2011; Lutz et al., 2005) have discussed the 
impact of chronic testicular pain on sexual function. Lutz et al. (2005) reported on a 
longitudinal sample of 1,248 Caucasian men (median age 60, range 40-79) residing in 
Olmsted County, Minnesota, with a regular sexual partner.  Five sexual function domains 
(libido, erectile function, ejaculatory function, problems with sexual function, overall 
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satisfaction) were assessed. Results demonstrated that the focal nature of testicular pain 
had a greater negative impact on the sexual function domain than with other domains. 
Although the association between generalized urogenital pain and sexual function was 
unclear, there was an association between testicular pain and decreased libido.  
More recently, Ciftci et al. (2011) conducted a descriptive study using a small 
sample of 50 men with orchialgia and 50 controls using the International Index of 
Erectile Function (IIEF). No significant difference in IIEF scores between groups for 
overall erectile function was noted (total score controls = 48.7 ± 12.10; total score men 
with testicular pain = 46.0 ± 10.9). Men with orchialgia reported decreased libido (score 
2.90 ± 1.4; controls 3.76 ± 2.2) and decreased satisfaction (score 2.94 ± 1.4; controls 3.50 
± 2.7) related to current sexual activity. Men with orchialgia also reported an overall 
lower quality of life score measured by the World Health Organization Quality of Life 
Questionnaire (9.7 ± 2.8 [range 0-12]) when compared with controls (6.8 ± 3.1). This 
suggests chronic testicular pain impacts both daily activities and overall quality of life. 
This study did not investigate other comorbid pain conditions that influence libido, such 
as depression or fatigue. Chronic pain may not change all aspects of male sexuality, but a 
genitourinary location may have a particularly profound impact both on function and on 
well-being. 
Overview of Chronic Unexplained Orchialgia 
Adult men with chronic orchialgia or chronic testicular pain are evaluated in 
primary care, urology (Ciftci, Savas, Yeni, Verit, & Topal, 2010) and pain clinics. 
Chronic unexplained orchialgia represents a challenging clinical entity for providers to 
successfully treat and manage because of its presently unclear etiology. There can be 
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straightforward explanations for seemingly chronic unexplained orchialgia (varicocele or 
referred pain from an inguinal hernia), but often the etiology remains unexplained. In 
fact, from 18.6% (Cifti et al., 2010) to 25% (Davis, Noble, Weigel, Foret, & Mebust, 
1990) of chronic orchialgia has no known cause, despite extensive evaluation.  
The three most often cited studies regarding chronic testicular pain (Costabile, 
Hahn, & McLeod, 1991; Davis et al., 1990; Schover, 1990) are over 25 years old and 
consist of a combination of retrospective and prospective chart review or interview 
(Schover, 1990), without inclusion of standardized psychometric tools. The history of 
sexual trauma reported in the Schover has never been substantiated or investigated in 
subsequent studies. The methodological limitation of these studies of chronic orchialgia 
provide only a sparse representation of the men with this condition and lack key details, 
such as pain comorbidities, quality of life or pattern of pain, to aid our understanding of 
this important men’s health condition. Past studies of CUO have focused on the success 
of invasive procedures without the inclusion of a control group, and serve as an example 
of the biomedical model proceeding without inclusion of psychosocial aspects, as noted 
in a recent integrative literature review (Quallich & Arslanian-Engoren, 2013). These 
same studies fail to report physical examination details, often resulting to the term 
“scrotal contents pain” in place of distinguishing among scrotal structures. 
The lack of rigorous studies threatens the external validity of currently proposed 
treatment algorithms or recommendations for treatment, and compromises the ability to 
predict or describe a phenotype for chronic orchialgia. Published studies do not routinely 
report demographic information except age, limiting the generalizability to other 
socioeconomic groups. The studies are commonly single-center, limiting generalizability 
 
 28 
to other countries or geographic areas. With the exception of visual analogue scales, 
previous studies have not included standardized assessment instruments, citing the 
rationale that there are no tools or instruments specific to, or validated in, this subgroup 
of men (Benson & Levine, 2012).  The current algorithm (Levine & Hoeh, 2015) for 
assessment and treatment of CUO minimizes psychosocial assessment in favor of 
surgical or medical intervention and is designed from only a urology perspective.  
The lack of rigorous evaluation of CUO in the literature closely parallels the 
history of interstitial cystitis (IC) and other urologic chronic pelvic pain syndromes 
(UCPPS), which until recently were evaluated from only a urology perspective, resulting 
in a record of unpredictable results and poor treatment success (Clemens, 2014). The shift 
in focus, due to large epidemiological studies (Multidisciplinary Approach to the Study 
of Chronic Pelvic Pain [MAPP], pointed toward the possibility of an underlying chronic 
pain syndrome in patients with UCPPS (Krieger, et al., 2015). Treating UCPPS from only 
the urology perspective did not take into account the multifactorial nature of what 
eventually would be identified as a chronic pain, not urologic, condition. A shift in focus 
from a strictly urology component of UCPPS included related disciplines (basic 
scientists, epidemiologists, pain specialists, neuroimaging, translational animal models) 
and refocused the investigation into the etiology of UCPPS, allowing for potential 
systemic syndromes that may have a relationship with UCPPS. Exploration of UCPPS 
through application of the principles of chronic pain resulted in progress toward 
identification of characteristics that UCPPS patients shared with other chronic pain 
populations. Two phenotypes of UCPPS patients have been identified, one with bladder-
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focused symptoms and one with more systemic, centralized pain (Clemens, 2014; Griffith 
et al., 2016; Krieger et al., 2015).  
There is no analogous literature base to allow comparison between men with 
CUO and other chronic pain groups. The only Cochrane review that discusses 
nonsurgical options for the treatment of chronic pelvic pain limits its discussion to 
options for women only (Cheong, Smotra, & Williams, 2014). Previous literature has 
failed to establish rigorous inclusion criteria that establishes testicular pain as truly 
localized and the only site of pain among study participants. As a result, authors reporting 
study participants with “testicular pain” may in fact have pain to any of the scrotal 
contents (e.g. testis, spermatic cord, epididymis, or the scrotal skin itself). This clouds the 
ability of clinicians to determine success and compare outcomes among reported 
interventions.  
Consistent failure to find a relationship between organic pathology and the reports 
of pain has fostered the belief that there is a psychologic component to CUO or that this 
condition represents a subtype of a “pain prone” population (Costabile et al. 1991). 
Conclusions about the true significance of CUO as a condition affecting men is limited 
by the lack of data reporting incidence, and this is influenced by the fact that there was 
not an individual ICD-9 code specific to this diagnosis (Quallich, & Arslanian-Engoren, 
2014).  This lack of knowledge has contributed to stigmatization of men with CUO, and 
research has neglected specific considerations that may address the unique needs of this 
male population. 
Previous Attempts to Categorize Chronic Orchialgia 
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 Pain that has been anatomically localized to the testis(es) has been described by a 
variety of concepts in the literature (Table 3). The name chosen to describe any condition 
can have significant implications, in the minds of providers, in the minds patients 
themselves and in the minds of the public and stakeholders. Including “pain” in the title 
implies that there is urgency for treatment. For clinicians who are familiar with the 
concepts used when treating chronic pain it also implies a multidimensional aspect to a 
patient's experience, as anticipated by the Biopsychosocial Model.  
 The International Association for the Study of Pain (IASP, 2011) and European 
Association of Urology (EAU) (Fall et al., 2010) guidelines (Table 3) include urinary and 
sexual function in men with chronic genital pain. The sparse literature on CUO does not 
reflect the presence of either lower urinary tract or sexual dysfunction (Quallich, & 
Arslanian-Engoren, 2013), calling into question any attempt to link chronic testicular 
pain with other urologic pain syndromes in men.  
The Need for a Concept Analysis 
 A concept analysis was vital to progression of the understanding of CUO, and was 
completed as independent study prior to the dissertation project (Quallich, & Arslanian-
Engoren, 2014). This allowed for the development of an initial conceptual definition for a 
phenomenon of interest. Chronic unexplained orchialgia needed a conceptual 
reexamination, one that was consistent with contemporary concepts about the 
multidimensional nature of chronic pain and its effects on daily life. Guided by Walker 
and Avant (2011), this concept analysis was conducted to clarify the concept for further 
study and distinguish CUO from other similar conditions.   
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 The need for a concept analysis was vital; there was no individual ICD-9 code for 
chronic orchialgia, making a true estimation of its incidence and prevalence challenging 
despite the sophisticated data tracking offered by contemporary electronic medical 
records (EMR). Papers have been published using a variety of terms, making 
comparisons among them difficult, and highlighting the challenges in successfully 
identifying the true nature of the CUO condition. The concept analysis provided a method 
to establish a solid conceptualization for CUO, and clarify the concept while providing a 
succinct definition that included its key attributes from the literature.   
A definition that reflects the complexity and individual nature of the chronic pain 
experience was developed: “Chronic unexplained orchialgia is a subjective negative 
experience of adult men, perceived as intermittent or continuous pain of variable 
intensity, present at least three months, localizing to the testis(es) in the absence of 
objective organic findings, that interferes with quality of life” (Quallich, & Arslanian-
Engoren, 2014, p. 1724).  
Model Case as Illustrative Sample of Focus for This Dissertation 
A model case offers an exemplar of a particular phenomenon while demonstrating 
its defining attributes (Walker & Avant, 2011). The following is a model case for chronic 
unexplained orchialgia:  
JS is a 43 year old Caucasian male presenting to Adult Urology clinic with 
complaints of chronic orchialgia lasting 32 months. His history is notable for 
spontaneous onset of right testicular pain while cooking at home with his wife. 
There is no history of genital trauma, infection or low back injury, and he has no 
urinary symptoms.  Previous visits to five different specialty providers, three of 
which were urologists, did not offer an explanation for his pain. He was offered a 
variety of medications, including non-steroidal anti-inflammatories, gabapentin, 
and tramadol, all resulting in little relief. The pain waxes and wanes independent 
of activity, position or rest. This pain has prevented him from pursuing his hobby 
of kayaking, decreased his productivity as an information technologies manager, 
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and limited his time as a middle school track coach. JS has undergone serial 
physical examinations and scrotal ultrasounds that have consistently been normal, 
and spermatic cord blocks have provided only a few hours’ relief.  To date, no 
explanation for his pain has been identified. 
 
Summary 
In general, the current state of the science regarding CUO is underdeveloped and 
incomplete. This represents both a gender gap and a disparity in the knowledge of this 
subpopulation of men with chronic pain. At the time of the 2013 integrative literature 
review, “chronic testicular pain” was chosen to describe this condition (Quallich, & 
Arslanian-Engoren, 2013). However, the 2014 concept analysis revealed that “orchialgia” 
was a more prevalent term in published literature, and “chronic unexplained orchialgia” 
now represents the phenomenon of interest (Quallich, & Arslanian-Engoren, 2014).   
This dissertation research is consistent with both the IOM 2011 report and the 
subsequent National Pain Strategy (NPS) (Mackey, 2014) that urge clinicians and 
researchers to focus on disparities in pain care. In this dissertation project, the specific 
disparity of interest is men with “high impact chronic pain” that is “associated with 
substantial restriction of participation in work, social and self-care activities for six 
months or more” (p. 9) as described by the IPRCC (2015).  This study establishes 
groundwork to understand CUO within a biopsychosocial model, and is the first study of 
its kind to evaluate men with chronic orchialgia with a rigorous approach using a 
combination of legacy instruments and newer psychometric instruments.  
The purpose of this dissertation research is to begin to address the gap in 
knowledge about a very precise subpopulation of men, one for whom there is a health 
disparity as regards chronic pain, specifically CUO. The long-term goal of this research 
trajectory is to promote a more comprehensive approach to pain assessment and treatment 
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for this subset of men, and offer insight into improving assessment of psychological traits 
or states that influence expectations, beliefs, and thoughts about the chronic pain that they 
experience and its impact in their lives. These insights have the potential for translation 
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Table 3  
Genital Pain Syndromes 
Organization 
or Author 
Year Term or 
Syndrome 
Definition Comments 
 Davis et al.  1991 Chronic 
orchialgia 
Intermittent or constant 
unilateral or bilateral testicular 
pain three months or longer in 
duration that significantly 
interferes with the daily 
activities of a patient so as to 
prompt him to seek medical 
attention (p.936) 
Localizes pain 
specifically to testis(es) 
Does not address the 
multiple potential 
domains affected by 
chronic pain 




Chronic pain that occurs in any 
portion of the scrotum or its 
contents (p. 209) 
Neglects differences in 
structure, function, or 
innervation of scrotal 
contents 
Does not address the 
multiple potential 











Persistent or recurrent episodic 
scrotal pain associated with 
symptoms suggestive of urinary 
tract or sexual dysfunction 
 
No proven epididymoorchitis or 
other obvious pathology 
Part of EAU chronic 







possible role of the 
pelvic floor as a 
contributor 
Does not address the 
multiple domains 










Occurrence of persistent or 
recurrent episodic pain localized 
within the organs of the scrotum 
that may be associated with 
symptoms suggestive of urinary 
tract or sexual dysfunction 
 
No proven infection or other 
obvious local pathology 
 
Often associated with negative 
cognitive, behavioral, sexual, or 
emotional consequences  as well 




as with symptoms suggestive of 











Occurrence of persistent or 
recurrent episodic pain perceived 
in the testis/testes and may be 
associated with symptoms 
suggestive of urinary tract or 
sexual dysfunction 
 
No proven infection or other 
obvious local pathology 
 
Often associated with negative 
cognitive, behavioral, sexual or 
emotional consequences as well 
as with symptoms suggestive of 
lower urinary tract and sexual 
dysfunction 
 
Previous terms have included 
orchitis, orchalgia, and 
orchiodynia; these terms are no 
longer recommended  
  










Occurrence of persistent or 
recurrent episodic pain perceived 
in the epididymis that may be 
associated with symptoms 
suggestive of urinary tract or 
sexual dysfunction 
 
No proven infection or other 
obvious local pathology 
Often associated with negative 
cognitive, behavioral, sexual, or 
emotional consequences as well 
as with symptoms suggestive of 
lower urinary tract and sexual 
dysfunction  
Part of IASP Taxonomy 
project 
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Feasibility Testing of a Male Chronic Genital Pain Clinic to Identify Men with  
Chronic Unexplained Orchialgia   
 
Introduction 
This study aimed to test the feasibility of a dedicated clinic for the evaluation of 
men with chronic male genital pain to address two patient care concerns. First, men with 
chronic genital pain complaints are perceived as challenging patients. Men with chronic 
genital pain scheduled can be disruptive within the normal pace of a clinic, as they 
commonly present with an extensive medical history and records from multiple prior 
providers and unclear treatment options. Second, the number of men with CUO were not 
captured clearly by ICD-9 codes. Furthermore, men with CUO are scattered amongst 
providers, making them a difficult group to identify for study. In the primary 
investigator’s practice setting, identifying men with chronic orchialgia would mean 
reviewing the daily schedules of several providers and traveling to any of eight clinic 
sites within the same healthcare system where men might be scheduled in order to 
approach them to participate in a research study. Therefore, the principle investigator 
embarked on a feasibility study to determine the practicality of establishing a small 
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subspecialty clinic within the urology department where she practiced .This subspecialty 
clinic would be dedicated exclusively to men with chronic genital pain patients, accepting 
referrals and managing follow-up care. In order to capture the greatest number of 
potentially appropriate referrals for the subsequent CUO study, this clinic was designated 
the “Chronic Male Genital Pain” clinic. 
Hypothesis 
This research was designed to generate data that begins to address the gaps in 
knowledge and test feasibility of a method for establishing a source population of men 
with chronic unexplained orchialgia for future study, from within a larger population of 
men with chronic genital pain.  
Aim 1. To test the feasibility of a method for identifying a source population of 
CUO for future study.  
Hypothesis: Establishing a specialized clinic for men with chronic genital pain 
will provide a source population pool of ~30% with true chronic unexplained 
orchialgia at time of clinic evaluation. 
Methods 
Design 
This was a feasibility study consisting of a convenience sample of men with male 
genital pain seen in an adult urology specialty clinic. The timeframe for the study was 
projected to be a year, which was deemed adequate for estimating feasibility of a clinic 
long-term. Because of the unclear number of referrals for chronic male genital pain to the 
urology department, coupled with the inability to accurately capture the number of these 
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men that previously seen due to nonspecific ICD-9 coding, there was not a way to 
estimate the number of men that were anticipated as referrals. 
Procedures 
Because of the principle investigator’s existing practice within the urology 
department at a large academic health system (UMHS), this new clinic had the advantage 
of not requiring additional clinic space or additional support staff.  Nevertheless, setting 
up this specific subspecialty clinic required a multi-step process involving many system 
and infrastructure steps (Appendix B). In brief, the clinic was initially opened every other 
Tuesday, beginning mid-June 2015. This “best guess” scheduling was designed to 
accommodate the lack of clarity regarding the true number of men with chronic genital 
pain evaluated by the department and the anecdotal consensus that it was “a fair amount”. 
Ongoing evaluation and adjustments to the schedule were anticipated to ensure men were 
scheduled appropriately (e.g., the clinic was not used to schedule infertility patients or 
vasectomy consults) and to accommodate increasing number of referrals, as needed. 
Based on the principle investigator’s previous experience with the complexity of patients 
of this type, coupled with the fact that UMHS is a tertiary referral center, new patient 
appointments were set at 45 minutes.  
Referral criteria were designed (Table 4) for the “Chronic Male Genital Pain 
Clinic”, including consult request guidelines that would be available to referring 
providers outside the University of Michigan Health System (UMHS). Expert opinion 
and the best available evidence from the literature formed the basis for these guidelines 
that directed the preliminary workup of men with chronic genital pain prior to referral to 
the clinic. Referral criteria suggested that men have a scrotal ultrasound within the 
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previous 3 to 6 months prior to referral, to ensure that men who needed urgent evaluation 
for testicular cancer were not inadvertently scheduled into this clinic. The absence of this 
imaging study did not preclude scheduling into the clinic. 
To capture the maximum number of referrals for chronic male genital pain, the 
principle investigator reviewed the diagnoses lists for each adult urology provider by 
hand, to determine which providers were seeing patients appropriate for referral into the 
new clinic. The next step was for the principle investigator to contact the providers who 
accepted these diagnoses (testicular pain, scrotal pain, penis pain, groin pain, or 
epididymal pain > 3 months) to ask if they would be willing to allow this alteration in 
scheduling, meaning these referrals would automatically be scheduled into the new clinic. 
Finally, the scheduling staff were instructed to contact the principle investigator  directly 
with any questions about scheduling referrals for male genital pain that originated in the 
community or from within UMHS. 
These steps of referring men into the clinic were considered as “primary 
screening” for the purposes of this feasibility study. The inclusion/exclusion criteria 
described in Chapter 4 were considered “secondary screening” for the purposes of 
specifically identifying amongst the men referred for chronic male genital pain those 
meeting criteria for the Chronic Unexplained Orchialgia (CUO) research.  
Inclusion Criteria for Primary Screening.  
The inclusion criteria for the Chronic Male Genital Pain clinic are as follow: men 
over age 18, have genital pain for more than 3 months, and be willing to be evaluated in 
this specialized clinic. The following definition developed after a recent concept analysis 
(Quallich, & Arslanian-Engoren, 2014) was used to guide evaluation of men with 
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potential CUO: “a subjective negative experience of adult men, perceived as intermittent 
or continuous pain of variable intensity, present at least three months, localizing to the 
testis(es) in the absence of objective organic findings, that interferes with quality of life” 
(p. 1724). 
Exclusion Criteria for Primary Screening.  
Men were excluded from primary screening at the clinic if they reported chronic 
non-genital pain (including chronic pelvic pain), acute genital pain or other urologic 
complaints. No adult men were excluded from referrals nor from the overall feasibility 
study based on their status as part of a minority group or subgroup. No specific attempts 
at recruitment of minority groups was made. Sexual orientation (queried on the history 
and physical form) or previous evaluation in a urology clinic or pain clinic did not 
exclude men from participating. 
Results  
Based on informal discussions with the principle investigator, support of this new 
clinic among urology providers and clinical staff was unanimous. No providers wished to 
retain referrals for chronic male genital pain. By number, the providers were urologists (n 
= 8), family practice physicians paired with the urology department (n = 3), and urology 
advance practice providers (n = 3) listed as accepting men with complaints of chronic 
male genital pain diagnoses (although frequently men were scheduled into available 
openings with providers not formally identified as accepting these diagnoses). 
Initial referrals were from within the urology department and other UMHS 
providers and few from urologists and primary care providers outside UMHS. Referral 
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for new patients from all sources totaled 107 during the 12.5 months of data collection. 
Referral for patients previously seen by other urology department providers totaled 22. 
The six weeks after the clinic opened few men were scheduled (n = 33) over three 
half-day clinics (Figure 3).  At the end of 2015, despite the modest number of men 
meeting the inclusion criteria for the CUO study, overall new referrals remained steady, 
averaging 26 per fiscal quarter (Figure 4). In 2016, the clinic opened every Tuesday. As 
of the third quarter of 2016, referrals directly to this clinic continued to increase (after 
data collection closed) from both within UMHS and from other health systems, especially 
from local providers in the Ann Arbor area. 
Designating a specialty clinic also clarified staffing decisions on these individual 
clinic days.  There was little need for nursing care/teaching or for additional medical 
assistant involvement, both which incur additional staffing costs. The 45-minute new 
patient appointments permitted adequate time for the nurse practitioner (principle 
investigator) to review the potentially extensive medical records of this patient group and 
proceed with evaluation of the individual men.  
The UMHS Department of Urology has over 38,000 visits yearly. Prior to the 
opening of this new clinic, 14 providers within the adult urology department accepted 
referrals for men with testicular or genital pain. During the study period of 12.5 months 
(June 16, 2015-June 30, 2016), a total of 228 men were scheduled into the newly 
established Chronic Male Genital Pain clinic (primary screening). Of these 228 patients, 
107 were new referrals, 15 patients were scheduled for a second opinion (previously seen 
by other providers within urology) and 106 had been seen previously by the principle 
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investigator for pain issues and scheduled for a return visit prior to start of this study 
(Figure 3).   
Of the 228 men who met primary screening (meaning scheduled into the Chronic 
Male Genital Pain clinic), 125 were deemed non-CUO at second level screening due to 
determination of pain or other presenting complaints at sites other than scrotal/testicular 
pain. The most predominant concern was erectile dysfunction without pain (n = 41), pain 
localized to the penis or early Peyronie’s disease (combined n = 21) and non-chronic 
genital pain (n = 27). Additional complaints that were not consistent with CUO are noted 
in format of a STROBE (Strengthening the Reporting of Observational Studies in 
Epidemiology) diagram (Figure 5). An additional 83 of the 228 men were deemed non-
CUO, due to identified etiologies, most predominantly bilateral varicoceles (n=46) and 
74 additionally identified conditions (Figure 5). A listing of treatments and coded 
diagnosis are shown in Tables 5 and 6 respectively. A treatment algorithm summarizing 
the processes of evaluation in specialty feasibility clinic is shown in Figure 6. 
Twenty men of the 228 men screened by the principle investigator met the study 
inclusion criteria for the CUO project (Chapter 4). Of these, all 20 consented and agreed 
to complete additional survey instruments. Survey instruments and additional contact 
with participants potentially could reveal additional reasons for their pain, but go beyond 
the scope of this first study focusing on establishing the clinic’s feasibility.  
Discussion 
 Of the 38,000 patients seen in the UMHS Department of Urology, results of this 
feasibility study revealed that less than 1% of men presented with true chronic 
unexplained orchialgia, as established a priori by conceptual criteria. This feasibility 
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study evaluated viability of a method for identifying a source population of CUO for 
future study. It suggests the potential benefits of a dedicated subspecialty clinic for CUO 
within an academic urology practice, led by a nurse practitioner; most of these men could 
be treated according to a known underlying cause of their condition. 
One of the most conspicuous outcomes was that far fewer men than originally 
anticipated had truly unexplained chronic orchialgia. Many men had an identified 
etiology for pain, and a source of pain that might respond to a surgical procedure. The 
number of men proceeding with surgery was not captured for this feasibility study, as 
conservative symptom management was the first course of treatment pursued during the 
timeframe of data collection. Despite the small sample of men with true CUO, 83 of the 
men who were thought to have CUO were provided with an accurate diagnosis. While 
this represents a positive clinical outcome, this did not support the initial hypothesis that   
~30% of men would be identified with true CUO at time of initial clinic evaluation. 
It is possible that a clinic designed to accommodate and fully evaluate patients for 
“unexplained” testicular pain may lead to referrals of non-surgical chronic pain patients, 
who required additional clinic time to more fully determine the underlying cause of their 
presenting complaint. The specialty clinic was designed for 45-minute appointments, 
which included adequate time for full record review. Furthermore, this finding of 
additional time for necessary evaluation, and creation of a clinic designed to provide that 
time supports a busy urological practice by allowing surgeons to focus on patients more 
likely to be surgical cases.  
This expanded appointment time was vital and allowed for a more in-depth 
assessment of their symptoms and avoiding a missed explanation for chronic pan.  Men 
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with chronic genital pain often present with record sets from multiple providers, or record 
sets that span many years. Men excluded from meeting CUO criteria had etiologies for 
their testicular pain that were readily identified with scrotal ultrasound (such as 
varicoceles or spermatoceles), a thorough history, and precise physical examination.  
Many men referred to the clinic with CUO presented without this imaging examination. 
This is particularly problematic in the case of ruling out high-risk entities such as cancer, 
as demonstrated by the single patient that was eventually diagnosed with a germ cell 
tumor as a result of his presentation to the Chronic Male Genital Pain Clinic.   
Findings from this study highlight that there may be a lack of standardized 
evaluation of this population. Although an algorithm (Levine & Hoeh, 2015) for 
evaluation of chronic orchialgia does exist, it is based on expert clinical opinion and few 
providers in the community may not be aware of this algorithm to guide their evaluation. 
This may highlight a system issue in the dissemination of knowledge relative to a 
particular urology and pain subpopulation. 
 Increased awareness of this clinic among providers within the Department of 
Urology dispelled misconceptions that it required additional nursing and medical 
assistant support. This began a pattern of internal referrals for chronic male genital pain, 
for men who had been evaluated by other adult urology providers and promoted 
consistent scheduling. Since the beginning of the focused Chronic Male Genital Pain 
clinic in UMHS adult urology, men have been gratified to know that there is a focused 
clinic for their specific complaints, making referrals to this specialty clinic easily 




Potential for Economic Implications  
Oomen et al. (2014) suggested that in a given urology environment “a single 
urologist specializes in TPS [testicular pain syndrome; synonym for CUO] in order to 
prevent superfluous diagnostics that lead to delays in treatment” (p. 1725) and further 
advocates for a multidisciplinary approach to chronic testicular pain management. The 
benefit of an NP in a specialty role promotes continuity of care within any department, 
and avoids urgent care, retail clinic and emergency room use for specific complaints (in 
this case chronic male genital pain). This specialty NP clinic helps to “sort” patients 
according to providers with the appropriate expertise and appropriate interest in category 
of patients and ensures timely access to care. 
Care provided by NPs and physicians has been repeatedly demonstrated 
equivalent for many chronic conditions (Horrocks, Anderson, & Salisbury, 2002; Stanik-
Hutt et al., 2013; Newhouse et al., 2011; Poghosayn, Boyd & Knutson, 2014). However, 
it is not difficult to extrapolate the quality of care from comparison studies in primary 
care, as many urology conditions benefit from chronic, episodic long-term care, a role 
uniquely suited to the NP. A recent RAND study (Auerbach et al., 2012) reported that an 
NP in the primary care setting may be salaried 20-35% less than a physician. This implies 
that inclusion of NPs in the urology is a likely cost-effective way to increase access and 
patient management, especially for conditions that can be managed non-surgically. The 
burden of urologic diseases in the US continues to rise due to the aging population, 
encouraging movement of NPs into urology.  This expansion of NPs into urology may 
eventually impact prices and utilization of urology services, although it is difficult to 
predict, as NPs cannot offer independent surgical services.  
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Urologic Diseases in America ([UDA], US Department of Health and Human 
Services, 2012) provides economic data for a variety of common conditions in urology. 
With the exceptions of erectile dysfunction and Peyronie’s disease surgeries, UDA does 
not report on male genital-specific surgeries. This creates an unknown in the surmised 
cost burden for surgical treatments of CUO. For example, there is no UDA data for 
surgeries that may successfully treat chronic testicular or scrotal pain (e.g., 
varicocelectomy, epidemectomy). The closest estimation is the cost for treatment of 
testicular cancer: 2006 charges across the US for ambulatory surgery (orchiectomy) 
totaled $23,609,028. Some men with CUO may undergo orchiectomy, like men with 
testicular cancer, but in (presumably) much smaller numbers. Table 7 shows cost 
averages at University of Michigan Health System for selected procedures that can be 
associated with treatment for men thought to have chronic unexplained orchialgia.  
Future Implications 
The results of this study emphasize the issue of who should see particular groups 
of patients, not solely who can. In a large academic center with many specialized clinics 
and providers, this new clinic offered innovative and streamlined care for men with CUO. 
Chronic unexplained orchialgia is not commonly a surgical or interventional diagnosis, 
likely making it less cost-effective for a trained surgeon to be the initial point of contact. 
Exploration of the clinic’s cost-effectiveness was beyond the scope of this initial 
feasibility study, but evaluation of cost comparison is a necessary component to consider 
in the future.  
The Chronic Male Genital Pain clinic now exists as a subspecialty referral option 
for providers who evaluate men with chronic genital pain, but currently excludes men 
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with pelvic pain complaints. Its ongoing goals are (a) patient evaluation, (b) coordination 
of referrals to other services, (c) education of men (and partners when present) regarding 
their ongoing management and evaluation needs, (d) discussion of their role in 
developing a treatment plan, and (e) emphasis of the individual’s role in his own self-care 
as a chronic pain patient. This new clinic may also decrease an unknown patient cost 
burden by avoiding multiple clinic appointments for the same presentation. This project 
is also consistent with the IOM (2011) mandate to take advantage of currently available 
services to promote the management of patients with chronic pain. 
Limitations 
Study limitations include that the scheduling process was subject to considerable 
sampling group contamination, as the result of a lack of precision in scheduling. Men 
with other GU concerns were scheduled into this clinic, either to meet mandated new 
patient access requirements or due to open appointments. A single provider (who was 
also the principal investigator) completing physical examination may be another 
limitation, and may have introduced bias. 
The strict inclusion criteria may have eliminated some men, such as those with 
chronic but episodic, rather than constant, pain that would have provided additional 
insight into chronic orchialgia. The inclusion/exclusion criteria prevented exploration of 
chronic orchialgia in the related population of men with chronic urologic pelvic pain 
syndrome (UCPPS) who often report chronic genital pain in addition to pelvic or perineal 
pain. Their inclusion may have expanded the numbers of men completing the instrument 
packet, adding additional strength to the study conclusions suggesting the characteristics 
of this chronic pain subpopulation. The costs of this clinic were not examined, although it 
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is anticipated that the clinic would have very low overhead in terms of supplies and 
staffing support. 
Conclusions and Clinical Implications 
In the absence of an evidence-based algorithm for treatment, men with CUO may 
pass back-and-forth among different providers and among different specialists. This 
feasibility study supported the initial aim to create a source population of men with CUO, 
although it was less than 30% anticipated. This research highlights the potential benefits 
of a subspecialty clinic that can fully accommodate the process for differential diagnosis 
for men presenting with complaints of chronic pain in the genital area. The clinic 
evaluation assured that the CUO label was appropriately applied only to the very few 
men without a meaningful known etiology, so that supportive care in living with these 
unknowns and symptoms can be offered.  
Considering the latter, it may be particularly beneficial for the specialty CUO 
clinic to be staffed by a nurse practitioner with expertise in non-operative urology 
diagnosis and treatments. The innovation represented by this unique clinic is that it 
directs the scheduling of a nonsurgical urology pain population, and focuses it to an 
expert nurse practitioner. It has the benefit of removing predominantly non-operative 
patients from the schedules of surgeons, allowing them to focus their clinic time toward 
patients who may need surgical intervention.  
This specialty clinic offers a more streamlined approach for men, in that they are 
scheduled with an expert provider who has the time, interest and skills to evaluate their 
specific concerns. The success of this feasibility project demonstrates the potential for a 
clinic designed to provide high-quality care to a specific population within urology, 
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building an infrastructure for research while also developing an evidence base that 
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Adult Male (> 18) Chronic Genital Pain Referral Guidelines 
Suggested pre-referral evaluation and 
management guidelines 
• Men with persistent genital pain (> 3 
months)  
• Emergent referral to Emergency Department 
if acute onset: see testicular pain guidelines 
• If concern for testicular mass: see testicular 
mass guidelines 
• This excludes patients with existing 
diagnoses, such as inguinal hernia, 
hydrocele, varicocele 
• Symptomatic management: 
• NSAIDs 
• discretionary use of narcotics 
 
Suggested additional testing and management 
prior to specialty clinic visit 
Patients should have a scrotal ultrasound on 
record within the last 3 to 6 months, or have one 
scheduled in advance of the clinic visit 
 
Specific patient education or information None 
 




Treatments Offered in the Chronic Male Genital Pain Clinic, Based on Suspected 
Etiology for Testicular Pain 
• Conservative, symptomatic management (e.g. use of compression shorts for support) 
• Discussion of varicocele repair, hydrocele repair, epididymectomy, cyst removal 
• Direction for management of constipation 
• Treatment of prostatitis 
• Referral for physical therapy (evaluation for posture, pelvic tilt, core strength 
abnormalities) 
• Referral for pelvic floor physical therapy 
• Trial of nonsteroidal anti-inflammatory drugs with or without muscle relaxers 
• Trial of neuromodulator medication 
• Referral to psychology or psychiatry for evaluation and management of stress-related 
issues or anxiety 
• Conservative management attempted before spermatic cord block or referral to 






Diagnoses* Coded for > 5 Visits in the Male Chronic  
Genital Pain Clinic 
 
ICD-9 code n Diagnosis 
608.9 101 Testicular/scrotal pain 
Scrotal pain 
Right or left testicular pain 
Orchialgia 
456.4 46 Bilateral varicoceles 
607.84 41 Erectile dysfunction 
789.09 26 Bilateral groin pain 
Right or left groin pain 
257.2 20 Hypogonadism 
608.98 18 Testicular cyst or  
Epididymal cyst 
608.86 18 Scrotal swelling 
607.9 17 Pain in penis or 
Penile pain 
608.9 10 Epididymal congestion pain or 
post-vasectomy pain syndrome 
278.01 10 Obesity 
456.4 9 Unilateral varicocele 
603.9 9 Hydrocele 
608.1 6 Spermatocele 
564.0 6 Constipation 

















Cost of Selected Outpatient Procedures Performed in the Context of CUO 
Procedure CPT Code Average cost at UMHS 
































* Code for use of microscope during the procedure. 
 
 
Figure 3. Utilization of Chronic Male Genital Pain Clinic June 15, 2015-June 30, 2016.  
NP: new patient to UMHS Urology; NP-2nd opinion: patient previously seen by UMHS urology 




Figure 4. Pattern of New Patient Referrals to Chronic Male Genital Pain Clinic by Fiscal 













Descriptive Case Series of Men with Chronic Unexplained Orchialgia 
Background 
Patients with chronic pain often present with multiple symptoms that frequently 
have a poorly defined etiology, and there are wide variations within any group of patients 
having an anatomically-defined pain complaint. These variations highlight the need in 
clinical research to carefully delineate observable traits, characteristics, behaviors, and 
burden as necessary to guide effective treatment for this specific subgroups of patients by 
stratifying  likely etiologic mechanisms. Ultimately, this should result in improved 
algorithms guiding treatment.  
Chronic unexplained orchialgia (CUO) is one such chronic pain syndromes, and 
clear etiological explanation. As such, clear and complete identification of variance in 
observable traits, characteristics, behaviors, and economic and psychological burden of 
the CUO syndrome is lacking. Recognition of these aspects is needed to establish 
contributions from any particular dimension of the multifactorial symptoms reported with 
CUO. This level of clinical detail can lead to logical progression of individualized 
treatment strategies and reduce frustration for patients with a trial-and-error approach. 
Currently, definitions of CUO are based on expert opinion rather than empirical evidence 
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and continue to undergo revision.  
Chronic male genital pain is currently classified by alleged anatomic site of pain. 
However, the possibility exists that this is not an accurate representation of the actual 
cause or pathway for this particular chronic pain. Recognition and treatment of CUO, 
along with establishing criteria for its prevention and assessment, lags significantly 
behind most other non-malignant genitourinary diagnoses (e.g. incontinence, interstitial 
cystitis, male-factor infertility, benign prostatic hyperplasia) increasing the burden to men 
and the healthcare system.  
Past investigations of CUO provide a sparse demographic representation of men 
with CUO and lack key details to aid understanding of this as a chronic condition. Past 
studies have not characterized specific pathophysiologies for CUO, reliable, effective 
therapies have not been identified, and exploration of men’s sexuality in a CUO context 
is lacking. 
Prevalence of CUO is unknown. It is possible that much of what falls under 
complaints of chronic testicular pain or chronic male genital pain may not reach 
specialists such as urologists or pain management specialists. Taken together, this creates 
a void in standardizing a process for evaluation and management within known variance. 
Data are also lacking relative to prevalence, onset, natural history, and outcomes of CUO. 
One estimate of prevalence among clinical patients used the method of simply asking 
nurse practitioners to estimate how many men with CUO were seen in their individual 
clinics in an average 30-day period (Quallich, 2016). Nurse practitioners estimated   a 
prevalence of 2.12%; the prevalence rose to 3.57% in the clinical sample of urology-
focused nurse practitioners and dropped to 1.77% in the clinical sample for generalist 
 
 71 
nurse practitioners (Quallich, 2016). But this best-guess estimate may not reflect an 
accurate prevalence, nor the larger sample of men with chronic genital pain who do not 
present to clinics.  
Given the lack of additional contemporary estimates of prevalence and the paucity 
of studies fully describing men with CUO there is a desperate need for data on variance 
in traits, characteristics, behaviors, and burden on men and their families.  Without this 
full descriptive data, comparisons with other chronic pain samples are limited.  
The long-term goal of this line of inquiry is building the evidence base for 
demographic, medical, psychosocial/ psychological characteristics of men with CUO 
along with their self-reported pain scores.  The short-term goal of this study is to 
begin the process through descriptive case series that can elicit variance in men’s 
descriptions about the experience of CUO.  
The significance of the work is that by administering an extensive battery of 
instruments to men with CUO, clinically relevant parameters may be identified that 
suggest specific aspects for further investigation on a larger scale. This case series study 
may also suggest subset of instruments for eventual use in everyday practice to guide 
treatment decisions.  
Aims and Hypotheses 
These aims and hypotheses are designed to generate data that begins to address 
the gaps in knowledge and establish a knowledge base of men with CUO to guide future 
study and treatment. 
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Aim 1. To determine the feasibility of asking men with CUO to complete a 
lengthy survey battery of tools (some with sensitive information) to in a group of 
men with CUO. 
Hypothesis 1: >80% of men diagnosed with true chronic unexplained orchialgia 
at time of clinic evaluation will fill out every survey instrument. 
Aim 2. Obtain pilot data to inform a future study designed to fully characterize 
the biopsychosocial aspects of CUO. 
Hypothesis 2: Men with chronic unexplained orchialgia will demonstrate 
comorbid symptoms associated with chronic pain. 
Methods 
Approval for data collection was granted by the Institutional Review Board of the 
University of Michigan (IRB-MED) eResearch ID: HUM00100294. Consent was 
obtained only after the clinic visit with the principle investigator had been concluded. The 
consent form emphasized that (a) choosing not to participate would not affect their care 
with Adult Urology at UMHS, and (b) the questionnaires would not be entered into their 
medical record. 
Design 
This pilot study used a cross-sectional design to explore the chronic pain 
experience of men with CUO, carefully diagnosed by having ruled out all known 
etiological underpinnings. For each CUO patient case identified, the man was asked to 
fill out an extensive, comprehensive battery of survey instruments (16 total). Instruments 
were chosen for their ability to measure the variety of domains represented by the 
Biopsychosocial Model (Engel, 1977) and the manner in which the blending of 
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biologic/physiologic, psychological, social and behavioral factors influence both one’s 
presentation and perception of pain. The study instruments were completed only once.  
Sample 
Twenty men with CUO were recruited from an academic urology department 
within a tertiary hospital system. Participants were approached to enroll in the study after 
completing a routine clinic visit with the urology nurse practitioner who confirmed they 
met study inclusion criteria.   
Participants were men older than age 18 referred to adult urology outpatient clinic 
at a tertiary care hospital system in the Midwest. Inclusion criteria included:  
• Agreement to complete the data collection survey instruments; 
• Reported pain that localized to one or both testes; 
• Reported response of at least “one” on pain, pressure or discomfort scales; 
• The primary investigator determined that the source of their pain was the 
testes, and had ruled out potential causes of scrotal content pain (e.g. 
spermatocele, post-vasectomy pain, inguinal hernias) and had truly 
unexplained pain at the time of the clinic visit.  
The exclusion criteria were modeled after the NIDDK’s Multidisciplinary 
Approach to the Study of Chronic Pelvic Pain (MAPP) study, as men with chronic genital 
pain, and specifically chronic orchialgia, are excluded samples in this large multicenter 
study (Clemens et al., 2014; Landis et al., 2014). Men were excluded from participation 
in the present study if they had orchialgia but also a previous diagnosis of  
• Interstitial cystitis (IC)/painful bladder syndrome (PBS)and/or chronic 
prostatitis (CP)/chronic pelvic pain syndrome (CPPS); 
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• An on-going neurological disease or disorder affecting the bladder or bowel; 
• Cystitis caused by tuberculosis, radiation therapy or Cytoxan/ 
cyclophosphamide therapy; 
• Augmentation cystoplasty or cystectomy; 
• Systemic autoimmune disorder (such as Crohn's disease or ulcerative colitis, 
lupus, rheumatoid arthritis, or multiple sclerosis); 
• Cancer (with the exception of skin cancer); 
• Major psychiatric disorder or other psychiatric or medical issues that would 
interfere with study participation (e.g. dementia, psychosis, upcoming major 
surgery, etc); 
• Severe cardiac, pulmonary, renal, or hepatic disease that in the judgment of 
the study investigator would preclude participation in this study;  
• Transurethral microwave thermotherapy (TUMT), transurethral needle 
ablation (TUNA), balloon dilation, prostate cryo-surgery, or laser procedure. 
No adult men were excluded from this study based on their status as part of a 
minority group or subgroup, and no specific attempts at recruitment of minority groups 
was made. Sexual orientation or previous evaluation in a urology clinic or pain clinic did 
not exclude men from participating; although the clinic intake forms survey sexual 
orientation, the aim was to capture as diverse a sample as possible.  
Study Instruments 
As part of the Chronic Male Genital Pain clinic visit, a supplemental history and 
physical form was administered to capture additional information that contributes to the 
evaluation and management of chronic pain conditions. Extensive descriptive information 
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was collected, including family history (including family members with a chronic pain 
condition), complementary and alternative medicine use, previous medications and 
procedures, past and specialty providers that the subject may have visited, and any 
secondary pain sites. 
Per the second aim of the study, extensive paper-based survey data was gathered. 
A primary consideration for this study is the fact that no psychometric tool has been 
established as reliable and valid in this particular chronic pain subsample.  However, all 
of the instruments selected have been validated in various chronic pain samples and in 
gender-specific samples.   
Instrument choice. 
The instruments chosen represent a combination of legacy instruments and newer 
instruments that reflect the contemporary understanding of the field of chronic pain 
(Table 8). Specific psychometric instruments were chosen because of their frequent use 
for the evaluation of chronic pain samples and their previously established reliable 
psychometric qualities. These instruments evaluate the domains of pain, types of pain, 
associated comorbid conditions and allied symptoms, mood and functional status. The 
multiple instruments demonstrate conceptual clarity, making them valuable in 
establishing sample characteristics, with the potential long-term goal of selection 
amongst these tools for best use in generating data needed on observable traits, 
characteristics, behaviors for chronic orchialgia to guide clinical practice in the future.  
The final set of instruments was chosen because most have been administered in 
pain samples, have validity data in male samples, and have proven stable factor 
structures. Additionally, this comprehensive set of instruments matches those used in the 
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Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) study. Choosing 
instruments that parallel many of those used in the MAPP study preserves the opportunity 
for eventual comparison of results from this project with those of the much larger MAPP 
effort, in which men with orchialgia were excluded. The 16 survey instruments chosen 
and organized by the Biopsychosocial Model is provided in Table 8, along with data on 
reliability. An alphabetized list of instruments with a brief summary description of each 
one is provided in Appendix C.  
 Many instruments were rejected for various reasons, and these instruments are 
listed in Table 9. Rejection of instruments was because they (a) were not validated with 
chronic pain patients, (b) overlapped with instruments that had been chosen, (c) or lacked 
strong psychometric properties.   
The instruments as a whole are subject to recall bias, as is typical of most survey 
instruments.  Each instrument selected was constructed at a 5th-6th grade reading level, 
considered to be relatively short tools to complete in and of themselves, and could be 
self-administered. Based on the literature, the selection of instruments could take up to 
40-60 minutes to complete. 
Data Management and Statistics 
Visual inspection of the 16 instruments prior to data entry did not reveal any 
individual items that were routinely unanswered. Data was entered into IBM SPSS® 
version 24 (IBM Corp., US). Raw data for the PROMIS instruments was uploaded to 
help@assessmentcenter.net, and transformed T scores were returned to the investigator 
via email. Raw data for the SF-12 instrument was similarly uploaded to OptumInsight 
Life Sciences, Inc., and after scores were transformed and a summary of the results was 
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made available through the OptumInsight web platform. Other study instruments were 
totaled or transformed as necessary. Results were subjected to normality checks via 
graphic display and using Shapiro-Wilks tests, as the sample size was small. The data 
were checked for outliers using boxplots or bar graphs. Initial analysis of the 
demographic data was completed with exploratory descriptive methods to evaluate for 
patterns by age groupings, medications or number of previous procedures.  
Results 
Of the 20 men who met the inclusion criteria, all 20 agreed to be consented to 
complete the study and survey instruments. Twenty men were provided with the full 
packet of 16 survey instruments and a supplemental history form exploring medication 
use and additional demographic information. Return rate for the completed survey battery 
was 70% (14 of 20). Of the 14 survey packets returned, 12 were completed in full, with 
only few individual items across the multiple instruments unanswered. The remaining 6 
packets were not returned.  Review of the instruments prior to data entry did not reveal 
any instruments that were routinely left blank or any individual items that were routinely 
unanswered. Few instruments had outliers, and these men were randomly distributed 
across the survey instruments. Table 10 presents results from all the survey instruments 
as median and range, as well as the dimension of chronic pain measured. 
Social Perspective Results. 
The median age in the study sample was 48.5 years (range 24-64). Additional 
demographics are shown in Table 11. No patients reported receiving disability payments 
and none were involved in pending legal action. Only one man had made use of 
complementary and alternative medicine treatment (acupuncture) and previous specialist 
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evaluation was limited to another urology provider (n = 5) or a pain specialist for back 
pain (n = 2). No participant reported an active opioid contract with any provider.  
Results on the SF-12 (Figure 7) revealed that 57% of the sample are at risk for 
screening positive for depression when compared with the general sample. Men 
demonstrated some limitations in self-care, physical, social, and role activities, as a result 
of bodily pain and fatigue. The participants demonstrated lower than instrument norm 
scores for self-care, walking, and involvement in physical activities on SF-12 scoring. 
Limitations were noted to typical role activities due to overall physical health, but men 
demonstrated sample norm values for general health. Social functioning and emotional 
role were limited, and participants demonstrated some overall compromise to emotional 
cognitive and intellectual function, as measured by the SF-12. 
Results on the SEAR (Table 10) demonstrate only mild-moderate issues with 
relationship satisfaction and high self-esteem and confidence in their sexual ability.  
Biology-based Perspective Results. 
Clinical information from the CUO sample is presented in Table 12; all results are 
median scores, due to the small sample size. The median duration of pain was 38.69 
months (range 3-72 months). 72 months represented an outlier that reported pain duration 
that was 28 months longer than the next longest time. A median of 76% of the overall 
pain complaint was associated with a primary site of pain, although two of the 14 men 
reported only 15-20% of their pain was from the testes. Table 13 shows information 
about oral medication use.  
Results from the American College of Rheumatology criteria measuring 
widespread and centrally-mediated pain (Wolfe et al., 2010) suggest this small sample 
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did not meet diagnostic criteria for a widespread pain syndrome (median score = 1.00). 
The sample demonstrated minimal-moderate interference from pain, based on median 
scores that were below threshold for diagnosis. Men did report some areas of pain in the 
last week that included left upper arm (n = 2) left lower leg (n = 2) abdomen (n = 1) 
lower back (n = 2) or neck (n = 1).  
Median American Urological Association Symptom Index (AUASI) scores  
(measuring lower urinary tract symptoms in men) demonstrated a low incidence of 
urinary symptoms (6.00); this total score indicates minimal urinary bother (Table 10). 
Median results on the Male Genitourinary Pain Index (M-GUPI) were midrange for the 
total instrument (19.00), and demonstrated low urinary symptoms (1.00) on the urinary 
subscale. Participants reported midrange median scores for the pain subscale (10.00) and 
moderate impact to quality of life on the QOL subscale (8.00). 
Biology/Psychology-based Perspective Results. 
Scores on the Brief Pain Inventory (BPI) (Table 10) demonstrated both moderate 
pain severity (19.00) and mild-moderate interference from pain, with a median pain score 
of 4.00. Results from the body map demonstrated both left (n = 8) and right groin (n = 3) 
were areas of increased pain in this sample, and that the scrotum (n = 11) was the primary 
site of most genital pain (n = 10), as the BPI body map does not specify testes. 
The total score (55.00) on the International Index of Erectile Function (IIEF) 
(Table 10) showed some moderate erectile dysfunction in the sample (Table 9). The 
orgasmic (10.00) and desire subscales (8.00) showed low dysfunction, and the overall 
satisfaction score (6.00) and intercourse satisfaction score (9.00) showed moderate to 
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high satisfaction. The erectile dysfunction subscale showed mild to moderate dysfunction 
(20.50).   
To further explore the data, a comparison between the median pain, worst pain, 
and current pain item individual item scores on the BPI and PainDETECT instruments is 
shown in Table 14. This comparison tested consistency in pain reporting in the study 
sample, as both measure the same concept and are measured on 10-point Likert scales. 
Median results for all three domains are similar. 
Psychology-based Perspective Results. 
Participants reported median midrange scores for all domains on the Beliefs in 
Pain Control Questionnaire (BPCQ), indicating indeterminate beliefs in the three 
concepts measured on this instrument (Table 10). Participants did not demonstrate clear 
evidence for internal locus of control (15.00), belief in chance happenings (11.00) or that 
“powerful doctors” control the course of their pain treatment (13.50). Median results on 
the Coping Strategies Questionnaire (CSQ) subscale demonstrated participants believe in 
a low control over their own pain (2.00) and evidence for little belief in their own ability 
to decrease their pain (2.00).  Participants showed low median scores for the overall 
instrument (5.00), indicating minimal evidence for catastrophizing in the study sample, 
although one participant scored very high (35.00). 
Participants demonstrated little evidence for depressed mood, as scored on the 
Hospital Anxiety and Depression Scale (HADS). This instrument (Table 10) showed a 
normal depression score (median 4.00) and a slightly higher median anxiety score (8.00). 
The CUO sample scored a median for fatigue of 58.35 on the Patient-Reported Outcomes 
Measurement Information System (PROMIS) Fatigue instrument, and a PROMIS sleep 
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disturbance median score of 54.8. Both PROMIS instruments demonstrated a gradual 
increase across the reported range of scores, without outliers.  
Patients reported self-identified an overall moderate decrease in their cognitive 
ability (Table 10) on the Multiple Ability Self-report Questionnaire (MASQ), most 
notable in the attention and concentration subscale (35.00) and language subscale (28.00). 
Other domain scores were midrange, indicating indeterminate decline to cognitive ability. 
Scores on the PainDETECT did not suggest a neuropathic cause for chronic 
orchialgia in this group. The median score on this instrument was 4.00, and overall 
median score was 12.38 (range 5-38); the 38 represented an outlier (Table 9).  
Results on the Positive and Negative Affect Schedule (PANAS) demonstrated 
more positive affect (median 34.00) in this group than negative affect (median 19.50).  
Results on both the instruments that evaluate trauma, the Childhood Traumatic 
Events Scale and Recent Traumatic Events Scale (CTES/RTES) instruments, 
demonstrated that death of a friend or family member was the most frequently reported 
source of trauma in this group, both as adults (n = 5) and as children (n = 6). Parental 
upheaval appeared as a factor for childhood trauma (n = 5). Four men reported a change 
in work in the previous 3 years. No participants reported a history of a traumatic sexual 
experience either as a child or an adult.  
Discussion 
This is the first project of its kind to extensively evaluate men with precisely 
defined chronic unexplained orchialgia using standardized psychometric tools. As a cross 
sectional study, it serves as the foundation for future studies seeking to evaluate this 
specific sample of men. Use of standardized psychometric tools promotes the comparison 
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of chronic unexplained orchialgia with other chronic pain samples, and begins to 
establish study feasibility and estimates of response ranges in men with CUO.  
This pilot sample demonstrated willingness to complete the extensive battery of 
tests, despite the extensive number of individual instruments. This offered an exploration 
of the multidimensional aspects of their pain experience, offering preliminary evidence 
for this study design as a feasible method for future date collection with this 
phenomenon. The personal nature of CUO made it uncertain that men would be open to 
questions about genital health, general pain or comorbid pain symptoms, despite their 
presentation in clinic seeking care. Hesitation to reveal details that did not seem directly 
related to their pain complaint may account for the six men who did not return the survey 
packets.  
Biopsychosocial Model Perspective on Results 
In terms of a social perspective, demographic results were similar to previously 
published results, with the exception of higher reported education and income than 
previously suggested by the literature (Davis et al., 1990; Costabile  et al., 1991). Results 
from the SF-12 (Figure 7) vary greatly from all other 15 study instruments in this pilot 
study, showing much greater decline in function across all its domains, and increased 
depression risk. If the SF-12 were the sole screening tool used, the CUO sample would 
seem much more functionally affected by chronic pain than summary scores from the 
other instruments used in this pilot study. 
Biologic perspective. 
The lack of urinary symptoms in this sample was consistent with the previously 
published literature review (Quallich, & Arslanian-Engoren, 2013). Participants reported 
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meager use of pain medications (Table 13) despite a lengthy list of medications that may 
have been prescribed or recommended.  In the CUO sample, there was no suggestion for 
a specific pain mechanism (e.g., centrally mediated pain) based on the American College 
Rheumatology criteria or PainDETECT results. Previous authors (Parekattil et al., 2013) 
offered evidence for a neuropathic component to chronic testicular pain.  
A single participant  (n = 1) scored very high on the PainDETECT, reported high 
interference on Brief Pain Inventory (BPI) pain interference subscale (9.57) and showed 
evidence for widespread pain based on the ACR criteria. This suggests that future 
investigations into CUO samples may uncover evidence for a subtype of chronic 
orchialgia that is more similar in presentation to other widespread pain conditions. 
Combined biologic and psychologic perspective. 
Evaluation from a combined biology and psychology perspective revealed that the 
sites of genital pain were consistent between two measures in this study (Male 
Genitourinary Pain Index [MGUPI] and Brief Pain Inventory [BPI]). However, the BPI 
did not specify testes as a site for pain. Men did identify right-sided testicular pain (50%) 
which is consistent with previous reports in the literature (Quallich, & Arslanian-
Engoren, 2013).  
Results on the  International Index of Erectile Function showed mild to moderate 
erectile dysfunction, lower orgasmic dysfunction and mild decrease to desire. This may 
be secondary to organic comorbidities, as well as demonstrating a contribution from 
chronic testicular pain. Self-esteem and Relationship Questionnaire scores showed a 
relatively high level of self-esteem and confidence in both relationships and sexual 
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function. This perspective has not been addressed in the literature, with the exception of a 
single study (Ciftci et al., 2011). 
Psychology perspective. 
Many of the psychological traits and allied comorbid symptoms reported with 
chronic pain were not evident in this sample. The sample showed low depression and 
anxiety scores, but no catastrophizing and low negative mood. This may be a function of 
the shorter duration of pain than previously reported in the review of the literature 
(Quallich & Arslanian-Engoren, 2013). The CUO sample median scored below the US 
sample mean for fatigue (58.35) but closer to the sample norm for sleep disturbance 
(median 54.8); the PROMIS fatigue results showed the most consistency with a chronic 
pain sample. Low catastrophizing in this group is consistent with their low median pain 
scores and suggests higher potential treatment success (Sullivan, 2009). Lower anxiety 
suggests the opportunity for increased treatment success. 
Little is known about specific coping styles of men who have chronic pain 
(Keogh, 2015). The results of the Beliefs in Pain Control Questionnaire were 
inconclusive as far as highlighting a particular coping style in the limited CUO study 
sample.  
Men in this sample showed moderate perceived deficit in language, attention/ 
concentration on the Multiple Ability Self-report Questionnaire subscales. The median 
scores in the CUO sample were worse than those reported for fibromyalgia patients (the 
exemplar group for centrally-mediated pain)  for the MASQ language and 
attention/concentration subscales (Williams, Clauw & Glass, 2011).  
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It is interesting to note that none of the participants in this study reported a history 
of traumatic sexual experience either as a child or within the last three years as an adult. 
This is in stark contrast to previous opinion in the literature, beginning with Schover in 
1990. This is the first and only contemporary study to investigate this dimension of social 
history and potential comorbidity for chronic pain. Although this is a small sample size, 
sexual trauma was not noted in this pilot study. Further investigation in a larger sample 
size is warranted, as a history of sexual trauma has been demonstrated to be a contributor 
to chronic pain for women.  
Comparison with Other Studies. 
Despite the limitations of a small sample size, this sample offers the opportunity 
to compare the present results with the sparse published studies that have investigated the 
chronic genital pain in specific male samples.  
Table 15 presents a comparison between IIEF scores in the present CUO sample 
and the sample from Ciftci et al. (2011). To date, these authors are the only paper to use 
of a standardized psychometric instrument, other than a visual analog pain scale, to 
measure other dimensions of chronic pain in men who have chronic testicular pain. They 
included 50 men using a broad inclusion criterion: “symptoms suggesting orchialgia” 
(Ciftci et al. 2011, p. 632). The CUO sample shows higher scores (better function) for the 
subscales, with the exception of the intercourse satisfaction and erectile function 
subscales. The similarities in the results between these two samples suggests that overall 
sexual function is affected by chronic orchialgia, either purely due to the site of 
discomfort with activity, the psychosocial burden of chronic pain or a different 
mechanism yet to be established. 
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Comparison across several instruments between the present CUO sample and 
early results from the male participants in the Multidisciplinary Approach to the Study of 
Chronic Pelvic Pain (MAPP) study is presented in Table 16. The samples share few 
similarities beyond age. The CUO sample reports a shorter duration of pain, a lower 
overall pain score, and an American Urological Association Symptom Index and Male 
Genitourinary Pain Index (MGUPI) scores total indicating little interference from urinary 
symptoms. The median scores for the MGUPI and its subscales demonstrate worse 
symptoms in the MAPP study group. Rates of anxiety are similar between the two groups 
and depression is slightly lower in the CUO sample. The MAPP group reported a much 
higher rate of erectile dysfunction as measured by the IIEF-6 (a shorter version of the 
International Index of Erectile Function). 
Clemens et al. (2015) reported that perineal pain appears to be a defining 
characteristic in male UCPPS. The CUO sample did not choose this as a site of pain 
either on Brief Pain Inventory or MGUPI. The contrast between these two groups calls 
into question the rationale for categorizing chronic orchialgia as a subset of male pelvic 
pain, although men with UCPPS do report testicular pain. When using the presence of 
urinary symptoms and urinary pain or bother as defining characteristic of the UCPPS 
group, the chronic orchialgia sample did not share those same characteristics. Chronic 
orchialgia may be a distinct clinical entity; the choice to mirror the MAPP instruments 
and exclusion criteria for this CUO study creates a “control” sample that can be 
compared with the results of the MAPP analysis. Including men with UCPPS in future 
explorations of chronic orchialgia will offer a larger sample sample, and will contribute 




Consistent with the design of the study, this project offers an intense look at small 
sample of 14 men. Interpretation of the results are limited by (a) the small sample size; 
(b) lack of geographic diversity; (c) lack of racial/ethnic diversity; (d) a convenience 
sample from a single institution.  These factors may inadvertently skew the results in 
terms of ethnicity and age, although this may be ameliorated by the fact that this 
academic setting serves as a tertiary referral center with a considerable watershed area 
from which referrals are generated.  
Statistical analysis of the instruments is also limited due to the small sample size 
and the variable number of men who completed each instrument. Not all instruments 
were completed by all participants, limiting the total number of responses for evaluation 
on some instruments. One explanation for lack of return of the surveys may be that the 
packet was quite extensive, requiring approximately 40 minutes to complete. Completion 
of the full instrument packet varied by individual, and may have been influenced by the 
position of the individual instrument in the packet order.  
Conclusion and Clinical Implications 
The cross-sectional sample is described in more detail than has been previously 
presented in the only recent integrative review of the literature (Quallich, & Arslanian-
Engoren, 2013). With the exception of visual analogue scales, previous studies have not 
included standardized assessment instruments, citing the rationale that there are no 
instruments specific to the CUO sample (Benson & Levine, 2012).  The larger 
implication is that by reporting sparse demographic data and the choice not to use 
psychometric instruments in previous interventional studies, this may have contributed to 
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men being treated with interventional procedures and surgery unnecessarily, potentially a 
cost both to them and healthcare as a whole.  
Performance on these instruments may also be in conflict with the actual clinical 
presentation. The report of pain as a chief complaint may be exaggerated, when 
compared with the rating on these instruments. The value of a thorough exploration of 
presentation with acknowledgment of the Biopsychosocial Model and the role of 
cognition in interpreting in maintaining chronic pain cannot be emphasized enough. 
Further study may suggest a causal or predictive model in this chronic pain subgroup that 
can be used to guide current treatment as well as future research.   
This collection of multidimensional self-report measures will be used to improve 
understanding of CUO presentation as a way to estimate sampling need for future grant 
applications and the long-term goal of creating a clinical phenotype. A description of 
observable traits and characteristics may provide a better understanding of potential 
etiologies for CUO and may suggest specific targets for treatment. This multidimensional 
assessement of men with CUO will offer insight regarding the natural history, and 
provide guidance for measuring responses to treatment. Establishing psychosocial and 
comorbid allied symptoms, in particular, can suggest a subsample of men with CUO that 
may benefit from care in specialties outside of urology. This study moves the state of the 
science towards a multidimensional understanding of men with CUO that can be used to 
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Table 9  
Instruments That Did Not Meet Selection Criteria 
Instrument Rationale for rejection 
Arizona Sexual Experience 
scale- ASEX 
5 questions 
Not specific to men; one of five questions changes based on gender but accurately 
measures presence of sexual dysfunction 
Validated for used with depressed individuals; was specifically developed to evaluate 
psychotropic drug-induced sexual dysfunction and changes in sexual dysfunction 
 




Developed to measure intensity of depression in patients with psychiatric diagnoses 
Also used to diagnose depression in normal samples 
Overlap with other instruments; goal of the project is not specifically evaluating 
depression in this sample 
 
Brief Sexual Function 
Questionnaire- BFSQ 
33 total questions 
Official description is 21 questions (some have multiple sections) 
Originally validated in depressed men; not widely used 
Confusing scoring protocol focuses on specific sexual difficulties in the clinical 






Identifies somatic conditions that usually accompany fibromyalgia 
Aid in identification of high symptom burden and provides  insight into decreased 
quality of life, decreased compliance with treatment, increase healthcare resource 
utilization, increase total healthcare cost 
Overlap with other instruments 
 
McGill Pain Questionnaire- 
MPQ 
20 item groupings 
Static measure of pain without temporal considerations 
Forces individual to select words that may not accurately describe pain 
 
 
Men’s Sexual Health 
Questionnaire- MSHQ  
25 items 
 
Validated only in men >65 
IIEF more widely used and recognized, allowing for better comparison with published 
data  
 




Sparse literature only suggests neuropathic origin for chronic unexplained orchialgia, 
this has not been concretely established 
Overlap with ACR criteria and PainDETECT 
 
Pain Anxiety Symptom Scale- 
PASS 
40 items 
Self-report instrument with four subscales 
Unclear assessment of pain-related fear or anxiety; overlap in assessment of 





Measures if individual is somatisizing, but not symptoms indicative of somatic 
syndrome 
More important to measure symptoms as insight into men that may be more difficult 





Although widely used, it has a lack of specificity for assessing established pain 
constructs 
 
Sickness Impact Profile- SIP 
136 items 
Long form 
Impact of illness on daily function; overlaps with dimensions of other shorter 
instruments 
 
Survey of Pain Attitudes- 
SOPA 
57 items 
Dimensions measured by this instrument (medical care, pain control, solicitude, 
disability, medication) are captured by other instruments 
In many studies, beliefs and coping are not clearly distinguish or defined, creating 
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Total score 19.00 10.00 35.00 Total instrument range 0-45; 
Higher score = worse symptoms. 
Pain subscale range                             
0-23; Urinary  subscale range 0-
10; Quality of life (QOL) 
subscale range 0-12. 
Total score:  
Pain subscale 
10.00 6.00 18.00 
Total score:  
Urinary  
subscale 
1.00 0.00 6.00 
Total score:  
QOL subscale 
 













n = 12 
Total score 32.00 13.00 82.00 Higher score = worse symptoms. 
*This is a percent on the 
instrument, range 0-100 
 
Total score range 0-110; pain 
severity score range 0-40; pain 
interference score   
range 0-70.  
Relief score* 2.00 0.00 9.00 
Pain severity 
 subcale 



















n = 11 
Total score 55.00 15.00 74.00 Total instrument range 5-75; 
higher score = less dysfunction. 
Erectile function range 1-30; 
Orgasmic function range 0-10; 
Sexual desire 2-10; Intercourse 










10.00 0.00 10.00 
Sexual desire 
subscale 





















n = 12 
Total score 40.50 29.00 65.00 Higher score = greater belief in 
the concept.  
Scores are totaled; Total possible 
score range 13-78;           
Internal locus range 5-30;  
Powerful doctors range 4-24;  
Chance happenings range 4-24. 
Internal locus of       
control subscale 




















n = 12 
 
Total score 5.00 0.00 35.00 Higher total score = higher 
catastrophizing (range 0-36).  




2.00 0.00 4.00 
Decrease pain 
item 









8.00 0.00 12.00 Scores are totaled, range 0-21. 
Higher score shows 



















n = 11 
Total score 116.00 110.00 132.00 Total instrument range 28-180; 
higher scores = more problematic 
perceptions. Language range 9-
45; Visual perceptual range 5-25; 
Verbal memory range 8-40; 
Visual spatial memory range 6-








10.00 7.00 16.00 
Verbal memory 
subscale 









35.00 33.00 38.00 
Psychology Comorbid allied 
symptom: Fatigue 
Patient reported outcomes 
measurement information system 
(PROMIS) Fatigue 
 n = 13 
T score 
58.35 
43.8 75.0 Scores are totaled after 
transformation, range 0-100.  
A score of 50 is the US  
sample norm; higher score is 
more of the measured concept. 
Psychology Comorbid allied 
symptoms: Sleep 
disturbance 
Patient reported outcomes 
measurement information system 
(PROMIS) Sleep Disturbance 
n = 13 
T score 
54.8 
44.8 76.5 Scores are totaled after 
transformation, range 0-100.  
A score of 50 is the US  
sample norm; higher score is 
more of the measured concept. 
Psychology Pain mechanism PainDETECT  
n = 13 
 










 subscale  
(n = 9) 
34.00 19.00 44.00 Scores are totaled, range 10-50. 
Higher score shows 
greater rate of positive/negative 
affect. Negative affect  
Subscale 
 (n = 12) 













n = 10 
Total score 55.51 24.90 94.29 Scores are totaled after 
transformation, range 0-100. 





















65.71 8.57 94.29 
 
Note. AUASI: American Urological Association Symptom Index; BPCQ: Beliefs in Pain Control; BPI: Brief Pain Inventory; CSQ: Coping Strategies Questionnaire; CTES/RTES: Childhood traumatic 
events scale/ Recent traumatic events scale; HADS: Hospital Anxiety and Depression Scale; IIEF: International Index of Erectile Function; MASQ: Multiple Ability Self-report Questionnaire; M-GUPI: 
Male Genitourinary Pain Index; PANAS: Positive and Negative Affect Schedule; PROMIS: patient reported outcomes measurement information system (NIH); QOL:quality of life; SEAR:Self-esteem 
and Relationship Questionnaire; SF-12: Short Form 
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Table 11.  
Demographics of Participants. 
Characteristic Result n 
Age (mean) 48.5  14 
Race and Ethnic Group Caucasian* 12 
African American 1 
Missing 1 
Relationship status Divorced/separated 2 
Unmarried couple 1 
Never married 3 
Married 7 
Missing 1 





Level of Education Graduate school 2 
College graduate 4 
Some college 5 
High school graduate 2 
Missing 1 
Household Income < 22500 3 
22500-45000 1 
45001-100000 1 
> 100000 6 
prefer not to say 1 
Missing 2 














Table 12.  
Clinical information (N = 14) 
Variable Result n 
Duration of pain (median in months) 38.69 14 
Patient reported genital site of pain Right 7 
Left 4 
Bilateral 3 
Diagnostic studies prior to chronic male genital pain 
evaluation 
Scrotal ultrasound 10 





Interventional procedures prior to chronic male genital 
pain evaluation 
Spermatic cord block 1 (helpful) 





Cyst removal 1 (little help) 
Family history of pain disorder   5 
Family history of anxiety or depression  3 
Family history of addiction  3 
 
Table 13 
Patient-reported Medication Use (Over-the-Counter or Prescribed) 




Ibuprofen 4 0 
Tramadol (Ultram®) 3 0 
Acetaminophen 2 1 
Hydrocodone and acetaminophen (Vicodin®) 2 0 
Aspirin 1 0 
Naprosyn 1 1 
Baclofen 0 1 
Cyclobenzaprine (Flexeril®) 0 1 
Gabapentin 0 1 
Metaxolone (Skelaxin®) 0 1 
Oxycodone and acetaminophen (Percocet®) 0 1 
Propoxyphene and acetaminophen (Darvocet®) 0 1 







Comparison of Pain Rating Scores Between Brief Pain Inventory (BPI) and PainDETECT 




















Pain right now 
Median 4.00 4.00 7.00 6.00 4.50 4.50 
Minimum 2 1 3 2 0 0 




Comparison of International Index of Erectile Function (IIEF) Scores 
Domain  CUO sample 
(median score) 
n = 11 
Ciftci, et al., 
2011 
n = 50 
Total score 55.00 46.0 ± 10.9 
Total score: 
Erectile function subscale 
20.50  
25.3 ± 3.2 
Total score: 
Orgasmic function subscale 
10.00  
6.31 ± 2.2 
Total score: 
Sexual desire subscale 
8.00  
2.90 ± 1.0 
Total score: 
Intercourse satisfaction subscale 
9.00  
8.58 ± 3.1 
Total score: 
Overall satisfaction subscale 
 
6.00  
2.94 ± 1.4 
Age   34.9 ±7.7 
Note. Total instrument range 5-75; higher score = less dysfunction. Erectile function  
range 1-30; Orgasmic function range 0-10; Sexual desire range 2-10; Intercourse  










Table 16  
Comparison of CUO Participants with Male MAPP Participants 
Measure CUO sample 
n = 14 
(Median 
scores) 




(2015)   
n = 191* 
Clemens et al. 
(2015) n = 
191+ 









38.69 < 24 
months 
n = 87 
< 24 
months 
n = 100 
 93.6  
Pain score BPI 4.00 
PainDETECT 
4.00   
 
   4.9  
AUASI total 
 








 24.6 24.57 ± 8.13 
n = 190 
MGUPI pain 
 




 12.2 12.21 ± 4.27 





1.00 4.2 ± 2.8 5.2 ± 
2.8 
  4.73 ± 2.86 





8.00     7.58 ± 2.78 




55.00   21.4 ± 
9.2 
  
HADS-D 8.00 5.2 ± 4.1 5.9 ± 
4.1 
  5.49 ± 4.09 
n = 190 
HADS-A 4.00 7.4 ± 4.4 7.5 ± 
4.3 
   
Note. MAPP: Multidisciplinary Approach to the Study of Chronic Pelvic Pain; AUASI: American 
Urological Association Symptom Index; HADS: Hospital Anxiety and Depression Scale; IIEF: 
International Index of Erectile Function; M-GUPI: Male Genitourinary  Pain Index. *Men with urologic 





Figure 7. SF-12 Report on Chronic Unexplained Orchialgia Sample. Image provided by 





Discussion, Conclusions and Future Directions 
This dissertation set out to examine two distinct perspectives on chronic 
unexplained orchialgia. The first was to explore the feasibility of a clinic dedicated to the 
evaluation of chronic male genital pain, with the goal of advancing clinical care. Its 
second purpose was to document the willingness of men to complete an extensive survey 
packet, and translate these results into a foundation for the clinical characterization of 
men with chronic unexplained orchialgia. 
Limitations of the Dissertation Approach 
There were acknowledged limitations to the studies conducted. The study design 
was exploratory and cross-sectional. Results are limited in their generalizability. For the 
feasibility clinic, the PI was already embedded within the general urology practice for 
this single academic medical center and with well-established clinical relationships. 
Generalizing success of establishing a Male Genital Pain Clinic to other medical center 
settings requires further testing. The clinic feasibility study was limited to one year, and 
hence sustainability is unknown. Formal cost analysis was not conducted.  
For the study on characterizing men with chronic unexplained orchialgia, this 
study’s generalizability is also limited. It incorporated only men drawn from a single 
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academic medical center, with little ethnic nor racial diversity, a narrow age group, 
mostly urban. This was a convenience sample and with small numbers.  
Despite these substantial limitations, this dissertation work does establish initial 
feasibility for a first clinic devoted solely to the identification of men with truly 
unexplained orchialgia. It raises the importance of both tangible and more intangible 
clinical benefits to the urology surgery faculty and the patients of a specialized nurse 
practitioner clinic to sort out diagnosis and treatment options for men with chronic genital 
pain and in particular chronic unexplained orchialgia. It provides foundational work for 
later full characterization of men with chronic unexplained orchialgia by careful selection 
of a broad array of survey instruments through a rigorous theoretical and data-driven 
processes. It documents adequate acceptability by these men for filling out this battery of 
tests.  
Recommendations 
The approach to men with chronic unexplained orchialgia introduced in this 
dissertation provides a natural guide to future research with this population. It provides 
preliminary evidence that a specialized clinic can succeed, with limited reallocation of 
resources within a surgical department. Additionally, it provides evidence that an expert 
nurse practitioner can successfully identify and manage a subtype of nonsurgical patients 
within urology, providing a cost-effective first point of contact (Figure 17). 
Pain is the most common reason that patients seek care and the most expensive 
public health issue in the United States, making pain management knowledge and 
education vital to the role of any healthcare provider. There is a need to acknowledge and 
invest in specialty chronic pain populations, such as those within urology, by developing 
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phenotypes and algorithms, similar to those currently being pursued by the 
Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) program, and 
recommended by the National Pain Strategy (IPRCC, 2015). There is a distinct benefit to 
categorizing and stratifying patients as a method for cost-effective evaluation and 
treatment. Poorly treated pain contributes to healthcare resource use, disability, and 
prescription drug use and abuse. 
It is vital to control costs, and identifying the most appropriate provider to see 
particular groups of patients, especially patients who are not traditionally operative in a 
surgical specialty, is imperative. This means identifying the potential needs of a patient 
population and matching them with the provider with a complementary set of skills 
training. This dissertation study has shown the success that is possible with more 
specialized evaluation for subgroup of men, with a provider able to blend the domains of 
urology, pain assessment and advanced nursing with a men's health perspective. 
While this pilot project represents a solid beginning to the development of a 
specialty practice and clinical characterization of men with CUO, the next logical step is 
to collect data from a larger cross-section of men, to improve the characterization and to 
continue to work towards a clinical phenotype. This dissertation project offers feasibility 
data to suggest that a possible future study design involving a large convenience sample 
could be successful. Inclusion and exclusion criteria will be similar to the ones for the 
Chapter 4 project.  
Following the lead of other chronic pain conditions, research should help move 
clinical care to improve the interdisciplinary approach to the treatment of CUO, with the 
goal of improving quality of life and treatment efficacy. Investigating individual genital 
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pain conditions may broaden our general understanding of pain conditions and suggest 
alternative treatments. Qualitative clinical characterizations of men, to improve clinical 
understanding of the biopsychosocial and biological risk for this chronic pain condition, 
will also allow for better comparison with other chronic pain populations. Long-term 
goals with the CUO population include the creation of an evidence-based, culturally 
sensitive prevention and care algorithm that is consistent with the National Pain Strategy 
and the perspective of the Biopsychosocial Model. 
Future Research and the Biopsychosocial Model 
It is imperative to move forward and establish biological, psychological, and 
social factors that contribute to CUO and to promote better prevention, diagnosis, and 
management, as these perspectives continue to represent a significant unknown in this 
population. This could involve the following: 
• Broadening the inclusion criteria to capture men who have episodic orchialgia or 
men who have other conditions such as urologic chronic pelvic pain (UCPPS) where 
chronic testicular pain is a component. This will help build a richer clinical 
characterization of men with chronic orchialgia; 
• Investigation of the clinical pain experience, beyond the neurosensory component.  
This could include qualitative exploration of the meaning of testicular pain as relates 
to sexual function and an individual's perception of sexuality. Assessing the effects 
of chronic pain in men relative to marital or partner concerns, as well as its impact 
on the family and social roles, will be an important perspective of placing this pain 
within a biopsychosocial context. This exploration could include documentation of 
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men's attempts at self-management for CUO: what has been successful and how 
successful, before they seek to care from any provider.; 
• Exploration of the biologic context of this chronic pain condition, including adding 
laboratory analysis in the workup of men with chronic unexplained orchialgia, 
including labs such as testosterone and cortisol. This could include an investigation 
of CUO association with other pain syndromes, especially urologic chronic pelvic 
pain syndrome (UCPPS), irritable bowel syndrome and other visceral pain 
syndromes; 
• Classifying patient characteristics that predict success of specific treatments to 
promote cost-effective matching of patient types to treatment modalities; 
• Moving toward use of quantitative sensory testing and brain imaging to investigate 
the potential for a central nervous system network of pathways in the pain 
experience that may be unique for men with CUO, or that may establish similarities 
with other pain populations.  
Contributions 
The following are the main research contributions of this dissertation project: 
• The development of a framework that presents in organized conceptual view of men 
with chronic unexplained orchialgia, highlighting the gaps in knowledge and the 
disparity in clinical approaches to their evaluation and treatment (Chapter 2). 
• The pursuit of an innovative approach to the care of a nonsurgical population of 
men, within an academic surgical department. This resulted in the development of a 
new “Chronic Male Genital Pain Clinic”. Specifically, the development of a clinic 
intended to provide both high-quality care, but also designed to create a platform for 
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the present dissertation project, and for ongoing data collection for future research 
on this population of men (Chapter 3). 
• Synthesis of the findings from the original review of the literature  (Quallich, & 
Arslanian-Engoren, 2013), the Biopsychosocial Model and a contemporary 
understanding of chronic pain, resulting in the choice of the survey instruments 
selected for data collection. This approach to data collection establishes the 
foundation for the multidimensional clinical characterization of men with chronic 
unexplained orchialgia (Chapter 4). 
Conclusion 
Care delivery within healthcare, and within surgical subspecialties, is changing. 
This research project was initially conceptualized by an expert nurse practitioner who 
recognizing the need to study a specific population of men in order to improve their care. 
An expert NP was able to independently staff a specialized men's genital pain clinic and 
provide an innovative and contemporary approach to the evaluation and management of 
CUO, a poorly described condition. This serves as a model for the utilization of anexpert 
NP that takes full advantage of the role, knowledge, and the blended medical and 
advanceg nursing approach. The impending shortage of trained urologists offers an 
opportunity for urologists and NPs to develop new strategies for care delivery, by 
expanding specialized clinical roles with previously marginalized populations, such as 
men with chronic unexplained orchialgia.  
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American Association of Nurse Practitioner 2016 National Nurse Practitioner (NP) 
Sample Survey: Selected Data. 
In 2016, the mean, full-time base salary for an NP was $102,526.  
 
The majority (60.7%) of NPs see three or more patients per hour.  
 
Malpractice rates remain low; only 1.9% have been named as primary defendant in a 
malpractice case. 
 
Nurse practitioners have been in practice an average of 12 years.  
 
Over 870 million patient visits to NPs are estimated in 2016. 
 
Average number of patients seen per day by NPs reporting a clinical focus in 
Urology/Nephrology:  20.2 ± 2.6. 




















Appendix A: Chronic testicular pain in adult men: an integrative literature review 




























































Building a Clinic Infrastructure 
In order to aim for efficiency in data collection of men with chronic orchialgia several system 
and infrastructure steps were necessary. It was simply not practical for the principle investigator 
to review the daily schedules of dozen providers and plan to be in any one of the six adult urology 
clinic sites to try and approach men to participate in my dissertation project. Since men with 
chronic genital pain complaints are typically challenging patients within the normal pace of the 
clinic schedule, it became clear that the most efficient manner for capturing these patients for 
potential participation in this CUO feasibility my study would be to designate particular clinics 
exclusively for chronic male genital pain referrals and follow-up. 
1. The plan to create a new clinic was discussed with the collaborating physicians. They 
approved of this proposal, realizing that not only would it help streamline their own clinic 
populations, but provide a service to these men by scheduling them with the provider 
who had both interest and the skills to give them a thorough evaluation. 
2. The plan was then presented to the clinical manager, for discussion and additional input. 
The proposal was for this new male genital pain clinic to take the place of a regularly 
scheduled clinic, since the principle investigator would be the primary provider 
evaluating these patients. This had the added benefit of not requiring either additional 
clinic space or additional support staff, as the clinic time was already designated for 
patients scheduled with the principle investigator. 
3. A set of referral criteria for the “Chronic Male Genital Pain Clinic,” including consult 
request guidelines that would be available to referring providers outside the University of 
Michigan Health System, was created. The collaborating physicians were approached for 
input. These guidelines were based on both expert opinion and the best available 
information pulled from the literature for the preliminary workup of men with chronic 
male genital pain. 
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4. The next step was to contact providers who had previously accepted these diagnoses 
(testicular pain, scrotal pain, penis pain, groin pain, or epididymal pain  > 3 months) to 
see if they would be willing to allow an alteration in scheduling, so that all of these 
referrals would automatically be scheduled into the new clinic. Support of this endeavor 
was unanimous, and there were no providers who wished to retain referrals. 
5. In order to try and capture referrals for chronic male genital pain to the adult urology 
department, it was necessary to review the diagnoses lists for each provider by hand in 
order to identify both physicians and mid-level providers who were currently accepting 
men with complaints of chronic genital pain. 
6. The principle investigator with the clinic manager on several occasions in order to design 
and have her eventually construct the scheduling grid for this clinic.  
7. Once the scheduling grid was set, the diagnoses from all other providers in the adult 
urology departments could be combined to ensure that referrals for chronic male genital 
pain would be directly scheduled into this new clinic. This involved turning over the 
master list of providers and their list of diagnoses to the adult urology call center staff, in 
order to remove the chronic male genital pain diagnoses from all other providers, and 
facilitate automatic scheduling into the new Chronic Male Genital Pain Clinic. 
8. Because of the unclear number of referrals for these issues to the department, coupled 
with the inability to accurately capture the number of these men that had been previously 
seen due to nonspecific ICD coding for this condition, there was no estimate for the 
number of men that could be anticipated as referrals in any given time. Because of this 
fact the clinic, was initially set up to run every other Tuesday, beginning mid-June 2015. 
9. Scheduling staff were instructed to contact the principle investigator directly with any 
questions about the appropriateness scheduling referral into this new clinic. 
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10. The initial six weeks after this clinic opened saw very few men who were scheduled. This 
was initially attributed to summer, when overall clinic attendance for non-urgent 
andrology issues can be slower. 
11. However, as few men continued to be scheduled into these new clinics, the principle 
investigator contacted the call center to make sure that the necessary changes had been 
made to the master scheduling guidelines. At this point it became clear that the diagnoses 
lists had not been collapsed and that men referred for chronic genital pain were 
continuing to go to multiple providers and to various clinical sites within the department. 
12. A meeting was scheduled between the call center staff and principle investigator to 
review the referral criteria, and to emphasize that all other providers had agreed to this 
change in schedulings for chronic male genital pain, and encourage them to be scheduled 
in the new Chronic Male Genital Pain Clinic. 
13. During this period of time there were multiple informal meetings with the clinic manager, 
trying to work through solutions that would allow for better utilization of this clinic. 
14. The principle investigator was also able to make providers within the Department of 
Urology aware of this clinic. This started a pattern of internal referrals for chronic male 
genital pain for men that had previously been evaluated by other adult urology providers. 
15. Fall of 2015 saw a slow and gradual increase in utilization of these new clinics, and the 












Summary of Instruments Used for Cross-sectional Study 
 
American College of Rheumatology Diagnostic Criteria for Fibromyalgia (ACR 
criteria) 
 The American College of Rheumatology diagnostic criteria for fibromyalgia was 
originally offered in 1990 (Wolfe, et al., 1990) and revised in 2010 (Wolfe et al., 2010). 
The instrument includes a pain map, a symptom severity scale score and somatic 
symptom score. Higher scores indicate worse symptomatology or increased body system 
involvement; the wide spread in his score for pain can range from 0 to 19 with a higher 
score indicating the involvement of more body locations. The symptom severity score 
ranges from 0 to 12 and this summed score includes an estimation of the number of 
associated somatic symptoms. The 2010 revision shifted the definition toward a more 
clinically useful classification for fibromyalgia, or centrally mediated pain, cases.  
American Urological Association Symptom Index (AUASI) 
 The American Urological Association Symptom Index (AUASI) was developed 
to address the urinary symptoms reported with benign prostatic hyperplasia in clinical 
populations (Barry et al., 1992; Chai et al., 1993). Higher scores indicate worse symptom 
bother, and the instrument is scored according to well-established range for little bother 
intermediate bother and general bother. 
Beliefs in Pain Control Questionnaire (BPCQ) 
 The Beliefs in Pain Control Questionnaire was developed to standardize invalid 
scale to measure beliefs about controlling pain in both clinical and nonclinical settings 
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(Skevington, 1990; Skevington, 1991). It provides a meaningful assessment of beliefs 
about pain control, whether there is an internal or external locus of control.  
Brief Pain Inventory (BPI) for Males 
 The Brief Pain Inventory (BPI) measures the participant subjective interpretation 
of his pain developed in 1994 (Cleeland & Ryan, 1994). A higher score in indicates more 
severe pain and greater pain-related interference. Its two-factor structure has been shown 
to be consistent (Cleeland, 2009) across cancer pain population and nonmalignant chronic 
pain patients. There has been less investigation of the factor structure reliability in 
nonmalignant chronic pain populations. For this study, the male specific form (BPI-M) of 
the instrument was used, which includes a male genital map for participants to indicate 
the site(s) of their pain. 
Six-item Catastrophizing Sub-scale from Coping Strategies Questionnaire (CSQ) 
 The Coping Strategies Questionnaire (CSQ) (Hirsh, George, Riley, Robinson, 
2007; Rosenstiel, & Keefe, 1983) measures patients’ use of pain coping strategies; only 
the items from the catastrophizing sub-scale were chosen for this project, to maintain a 
parallel structure with the MAPP project. Higher scores indicate higher catastrophizing, 
and may translate into higher pain scores. 
Childhood Traumatic Events Scale/ Recent Traumatic Events Scale (CTES/RTES) 
This instrument is composed of two forms one that investigates childhood trauma 
before age 17 and one that investigates traumatic events in the last three years 
(Pennebaker & Susman, 1988). Both measure similar domains including death of a close 
family member, serious illness, and sexual assault. Participants are asked to rate their 
experiences on a six-point Likert scale The instrument is scored based on individual 
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items, or totaled for some across all traumas, and asks if participants confided about the 
trauma. 
Hospital Anxiety and Depression Scale (HADS) 
 The Hospital Anxiety and Depression Scale was developed in 1983 (Snaith & 
Zigmond, 1986; Zigmond & Snaith, 1983). HADS is designed to screen for anxiety and 
depression (in patients with physical health problems. Items were selected to provide for 
the greatest distinction between anxiety and depression, while excluding items that might 
reflect somatic symptomatology.  Scoring of the instruments has been clearly established: 
0 to 7 indicates no anxiety or depression; 8 to 10 suggests anxiety or depression; 11 to 21 
indicates anxiety or depression. Higher scores on this instrument indicate higher distress.  
International Index of Erectile Function (IIEF) 
 This instrument was developed specifically to assess erectile function by patient 
self-report and was designed to be sensitive to treatment changes (Rosen, et al., 1997; 
Rosen, 1998). It evaluates five separate domains of sexual function and is consistent with 
the NIH definition for erectile function, and was designed to meet the needs of regulatory 
agencies across the world (Rosen, Cappelleri, & Gendrano, 2002).  
Multiple Ability Self-report Questionnaire (MASQ) 
 The Multiple Ability Self-report Questionnaire (MASQ) was developed in 1994 
(Seidenberg, Haltiner, Taylor, Hermann, & Wyler, 1994). Higher scores equal a greater 
degree of self-reported cognitive difficulty. To date it has unclear validation specifically 
in men with chronic pain.  
Male Genitourinary Pain Index (M-GUPI) 
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 The Male Genitourinary Pain Index is a 10 item instrument designed specifically 
to measure genitourinary pain in men (Clemens, et al., 2009).  The total score ranges 
from 0 to 45, with a higher score indicating worse symptoms. It measures three factors: 
pain, urinary symptoms, and quality of life. It has been validated specifically in men with 
genitourinary pain diagnoses and is an integral instrument in the NIH MAPP study.  
PainDETECT 
 This instrument uses the IASP taxonomy for the definition of neuropathic pain: 
“pain resulting from a lesion or dysfunction of the peripheral or central nervous system”. 
It was developed in 2006 (Freynhagen, Baron, Gockel, & Tölle, 2006) after review of the 
literature to determine factors relative to the patient experience of neuropathic pain 
syndromes. Responses less than or equal to 12 indicate an unlikely neuropathic 
component to pain, while results greater than or equal to 19 indicate a likely neuropathic 
component. Responses that fall in between this range indicate a physical examination is 
required for diagnosis. Since its original development, a body chart or body map has been 
included. 
Positive and Negative Affect Schedule (PANAS) 
 The Positive and Negative Affect Schedule (PANAS) was designed to measure 
subjective distress and positive emotionality (Watson, Clark, & Tellegan, 1988). It has 
been validated both clinical and nonclinical populations (Crawford & Henry, 2004), and 
have been proven to be stable in a variety of time frames. Higher scores on the positive 
affect items reflect higher levels of positive affect, while lower scores on the negative 




 In 2004, the NIH began its Patient Reported Outcomes Measurement Information 
System (PROMIS) initiative with the goal of establishing a framework and items for a set 
of both adult and pediatric item banks. The PROMIS network used a modified Delphi 
approach, multiple rounds of framework review and revision to create domains and items 
for specific domains (Cella, et al., 2010; Cella et al., 2007). Existing legacy outcome 
questionnaires created the initial item bank for the NIH steering committee to use in their 
selection of specific items that would eventually comprise the new questionnaires. Items 
from well-established, well-validated psychometric instruments were subjected to a 
rigorous literature review to choose items that fit the specific domain definitions that had 
been chosen. PROMIS workgroups sorted through thousands of items according to 
content and decided which items were most representative of their individual domains. 
Resulting items were subject to expert review and revision, with specific attention paid to 
content, clarity and readability. The resulting panel of items were subjected to two waves 
of testing, resulting in calibrated item banks, most of which utilize a seven-day recall 
period. The resulting PROMIS instruments have been tested for use in clinical research, 
clinical care, and validated in both genders as part of the PROMIS project. 
PROMIS Fatigue 
 The PROMIS fatigue definition is “an overwhelming, debilitating, and  
sustained sense of exhaustion that decreases one's ability to carry out daily activities, 
including the ability to work effectively and to function at one's usual level in family or 
social roles” (Cella, et al., 2007). A higher score equals worse function or more 
symptoms, and individual items have been pulled from legacy instruments. 
PROMIS Sleep Disturbance 
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 The PROMIS sleep definition is “a rapidly reversible, current state of reduced 
(but not absent) awareness of and interaction with the environment” (Cella, et al., 2007). 
A higher score equals worse function or more symptoms; it provides a general measure of 
sleep disturbance. It has an unclear responsiveness to change in sleep pattern over time. 
Individual items have been pulled from legacy instruments.  
Self-esteem and Relationship (SEAR) 
 The Self-esteem and Relationship questionnaire was developed to specifically 
address psychosocial issues related to erectile dysfunction (Althof, et al., 2003). It was 
designed as a measure for the emotional toll that erectile function can have on men, and 
detect meaningful clinical changes over time (Cappelleri et al., 2004). Some questions are 
reverse scored, and a higher score signifies a more favorable response for all 14 items. 
Short Form 12 (SF-12) 
 The SF-12 was originally developed in 1996 (Ware, 1996), rooted in 
psychometric instruments used since the 1970s. While there is a complicated scoring 
algorithm, higher scores equal better health; its summary scores are very similar to those 
seen on the SF-36 (Jenkison & Layte, 1997).  
 
